Athene Holding Ltd.
For the period ended Jun 30, 2025. Filed Aug 7, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 7, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Condensed Consolidated Financial Statements (unaudited)
- Business, Basis of Presentation and Significant Accounting Policies
Athene Holding Ltd. (AHL), together with its subsidiaries (collectively, Athene, we, our, us, or the Company), is a leading financial services company that specializes in issuing, reinsuring and acquiring retirement savings products in the United States (US) and internationally. We are a direct subsidiary of Apollo Global Management, Inc. (AGM, and together with its subsidiaries other than us or our subsidiaries, Apollo).
We conduct business primarily through the following consolidated subsidiaries:
Our non-US reinsurance subsidiaries, to which AHL’s other insurance subsidiaries and third-party ceding companies directly and indirectly reinsure a portion of their liabilities, including Athene Life Re Ltd. (ALRe), Athene Annuity Re Ltd. (AARe) and Athene Life Re International Ltd. (ALReI); and
Athene Annuity and Life Company (AAIA), our parent US insurance company, and its subsidiaries.
In addition, we consolidate certain variable interest entities (VIEs) for which we have determined we are the primary beneficiary. See Note 4 – Variable Interest Entities for further information on VIEs.
Consolidation and Basis of Presentation—We have prepared the accompanying condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (US GAAP) for interim financial information and the United States Securities and Exchange Commission’s rules and regulations for Form 10-Q and Article 10 of Regulation S-X. The accompanying condensed consolidated financial statements are unaudited and reflect all adjustments, consisting only of normal recurring items, considered necessary for fair statement of the results for the interim periods presented. Certain reclassifications have been made to conform with current year presentation. All intercompany accounts and transactions have been eliminated. Interim operating results are not necessarily indicative of the results expected for the entire year.
For entities that are consolidated, but not wholly owned, we allocate a portion of the income or loss and corresponding equity to the owners other than us. We include the aggregate of the income or loss and corresponding equity that is not owned by us in noncontrolling interests in the condensed consolidated financial statements.
The condensed consolidated balance sheet as of December 31, 2024 has been derived from the audited financial statements, but does not include all of the information and footnotes required by US GAAP for complete financial statements. Therefore, these condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2024. The preparation of financial statements requires the use of management estimates. Actual results may differ from estimates used in preparing the condensed consolidated financial statements.
Summary of Significant Accounting Policies
Income Taxes—Any difference between the tax provision (or benefit) allocated to us under the separate-return method and payments to be made to (or received from) AGM for tax expense is treated as either a dividend or a capital contribution.
In 2025, we executed a US and UK tax sharing agreement with AGM. As a result of this tax sharing agreement, AGM made a tax settlement payment to us for the usage of a portion of our tax attributes. We previously recorded deferred tax assets (DTA) for these tax attributes in our separate company financials. We have elected to distribute these hypothetical DTAs and no longer include them on our separate company balance sheet. We will continue to evaluate the likelihood of realizing the benefit of these hypothetical deferred tax assets and may record a valuation allowance for these hypothetical DTAs, if based on all available evidence, we determine that it is more likely than not that some portion of the tax benefit will not be realized on a separate company basis.
Recently Issued Accounting Pronouncements
Business Combinations and Consolidation – Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity (Accounting Standards Update (ASU) 2025-03)
This amendments in this update clarify the guidance in determining the accounting acquirer in a business combination involving a VIE. The amendments require that an entity apply the general guidance of identifying the Acquirer under ASC 805, Business Combination, even when the legal acquiree is a VIE and the transaction is primarily effected by exchanging equity interests. This guidance is effective for us for the 2027 annual and interim periods; early adoption is permitted. The amendments are required to be applied prospectively to any acquisition transaction that occurs after the initial application date. We are currently evaluating the impact of this guidance on our consolidated financial statements.
Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures (ASU 2024-03)
The amendments in this update require disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. The ASU requires tabular presentation of each relevant expense caption on the face of the income statement including employee compensation, depreciation, intangible asset amortization and certain other expenses, when applicable. The guidance is effective for us for the 2027 annual period and in interim periods in 2028; early adoption is permitted. We are currently evaluating the impact of this new guidance on our consolidated financial statements.
Income Taxes—Improvements to Income Tax Disclosures (Accounting Standards Update (ASU) 2023-09)
The amendments in this update revise certain disclosures on income taxes including rate reconciliation, income taxes paid, and certain amendments on disaggregation by federal, state and foreign taxes. The guidance is effective for us for annual periods beginning in 2025. Early adoption is permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements.
Adopted Accounting Pronouncements
Compensation – Stock Compensation (ASU 2024-01)
The amendments in this update clarify how an entity determines whether it is required to account for profits interest awards (and similar awards) in accordance with Accounting Standards Codification (ASC) 718 Compensation – Stock Compensation or other guidance. The ASU provides specific examples on when profits interest awards should be accounted for as a share-based payment arrangement under ASC 718 or in a manner similar to a cash bonus or profit-sharing arrangement under ASC 710 Compensation – General or other ASC topics. We adopted this guidance effective January 1, 2025. The adoption of this update was applied on a prospective basis and did not have a material effect on our consolidated financial statements.
Business Combinations – Joint Venture Formations (ASU 2023-05)
The amendments in this update address how a joint venture initially recognizes and measures contributions received at its formation date. The amendments require a joint venture to apply a new basis of accounting upon formation and to initially recognize its assets and liabilities at fair value. The guidance is effective prospectively for all joint ventures formed on or after January 1, 2025, while retrospective application may be elected for a joint venture formed before the effective date. The adoption of this update was applied on a prospective basis and did not have a material effect on our consolidated financial statements.
- Investments
AFS Securities—Our AFS investment portfolio includes bonds, collateralized loan obligations (CLO), asset-backed securities (ABS), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS) and redeemable preferred stock. Our AFS investment portfolio includes related party investments, primarily comprised of investments over which Apollo can exercise significant influence, which are presented as investments in related parties on the condensed consolidated balance sheets, and are separately disclosed below.
The following table represents the amortized cost, allowance for credit losses, gross unrealized gains and losses and fair value of our AFS investments by asset type:
| June 30, 2025 | |||||
|---|---|---|---|---|---|
| (In millions) | Amortized Cost | Allowance for Credit Losses | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
| AFS securities | |||||
| US government and agencies | $10,117 | $— | $67 | $(1,161) | $9,023 |
| US state, municipal and political subdivisions | 1,068 | — | — | (228) | 840 |
| Foreign governments | 2,260 | — | 52 | (560) | 1,752 |
| Corporate | 103,597 | (174) | 1,237 | (10,097) | 94,563 |
| CLO | 30,620 | — | 868 | (100) | 31,388 |
| ABS | 27,405 | (130) | 563 | (476) | 27,362 |
| CMBS | 13,854 | (62) | 102 | (394) | 13,500 |
| RMBS | 10,716 | (394) | 322 | (322) | 10,322 |
| Total AFS securities | 199,637 | (760) | 3,211 | (13,338) | 188,750 |
| AFS securities – related parties | |||||
| Corporate | 2,556 | — | 54 | (41) | 2,569 |
| CLO | 7,384 | — | 163 | (9) | 7,538 |
| ABS | 12,003 | (1) | 36 | (229) | 11,809 |
| Total AFS securities – related parties | 21,943 | (1) | 253 | (279) | 21,916 |
| Total AFS securities, including related parties | $221,580 | $(761) | $3,464 | $(13,617) | $210,666 |
| December 31, 2024 | |||||
|---|---|---|---|---|---|
| (In millions) | Amortized Cost | Allowance for Credit Losses | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value |
| AFS securities | |||||
| US government and agencies | $8,413 | $— | $8 | $(1,270) | $7,151 |
| US state, municipal and political subdivisions | 1,167 | — | — | (246) | 921 |
| Foreign governments | 2,082 | — | — | (514) | 1,568 |
| Corporate | 95,006 | (175) | 485 | (11,731) | 83,585 |
| CLO | 29,524 | — | 266 | (608) | 29,182 |
| ABS | 24,779 | (76) | 138 | (640) | 24,201 |
| CMBS | 11,158 | (60) | 75 | (432) | 10,741 |
| RMBS | 8,587 | (397) | 228 | (403) | 8,015 |
| Total AFS securities | 180,716 | (708) | 1,200 | (15,844) | 165,364 |
| AFS securities – related parties | |||||
| Corporate | 2,502 | — | 18 | (59) | 2,461 |
| CLO | 6,130 | — | 18 | (113) | 6,035 |
| ABS | 10,899 | (1) | 21 | (288) | 10,631 |
| Total AFS securities – related parties | 19,531 | (1) | 57 | (460) | 19,127 |
| Total AFS securities, including related parties | $200,247 | $(709) | $1,257 | $(16,304) | $184,491 |
The amortized cost and fair value of AFS securities, including related parties, are shown by contractual maturity below:
| June 30, 2025 | ||
|---|---|---|
| (In millions) | Amortized Cost | Fair Value |
| AFS securities | ||
| Due in one year or less | $2,385 | $2,355 |
| Due after one year through five years | 25,853 | 25,861 |
| Due after five years through ten years | 29,743 | 28,473 |
| Due after ten years | 59,061 | 49,489 |
| CLO, ABS, CMBS and RMBS | 82,595 | 82,572 |
| Total AFS securities | 199,637 | 188,750 |
| AFS securities – related parties | ||
| Due after one year through five years | 1,142 | 1,150 |
| Due after five years through ten years | 823 | 832 |
| Due after ten years | 591 | 587 |
| CLO and ABS | 19,387 | 19,347 |
| Total AFS securities – related parties | 21,943 | 21,916 |
| Total AFS securities, including related parties | $221,580 | $210,666 |
Actual maturities can differ from contractual maturities as borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.
Unrealized Losses on AFS Securities—The following summarizes the fair value and gross unrealized losses for AFS securities, including related parties, for which an allowance for credit losses has not been recorded, aggregated by asset type and length of time the fair value has remained below amortized cost:
| June 30, 2025 | ||||||
|---|---|---|---|---|---|---|
| Less than 12 months | 12 months or more | Total | ||||
| (In millions) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| AFS securities | ||||||
| US government and agencies | $1,724 | $(74) | $3,206 | $(1,087) | $4,930 | $(1,161) |
| US state, municipal and political subdivisions | 65 | (3) | 768 | (225) | 833 | (228) |
| Foreign governments | 146 | (6) | 1,411 | (554) | 1,557 | (560) |
| Corporate | 13,910 | (568) | 41,302 | (9,500) | 55,212 | (10,068) |
| CLO | 6,179 | (20) | 1,697 | (77) | 7,876 | (97) |
| ABS | 5,044 | (157) | 3,475 | (240) | 8,519 | (397) |
| CMBS | 4,277 | (77) | 1,529 | (261) | 5,806 | (338) |
| RMBS | 565 | (9) | 1,129 | (123) | 1,694 | (132) |
| Total AFS securities | 31,910 | (914) | 54,517 | (12,067) | 86,427 | (12,981) |
| AFS securities – related parties | ||||||
| Corporate | 371 | (12) | 372 | (17) | 743 | (29) |
| CLO | 2,213 | (7) | 159 | (2) | 2,372 | (9) |
| ABS | 2,997 | (16) | 3,678 | (198) | 6,675 | (214) |
| Total AFS securities – related parties | 5,581 | (35) | 4,209 | (217) | 9,790 | (252) |
| Total AFS securities, including related parties | $37,491 | $(949) | $58,726 | $(12,284) | $96,217 | $(13,233) |
| December 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| Less than 12 months | 12 months or more | Total | ||||
| (In millions) | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses |
| AFS securities | ||||||
| US government and agencies | $3,010 | $(114) | $3,462 | $(1,156) | $6,472 | $(1,270) |
| US state, municipal and political subdivisions | 67 | (3) | 842 | (243) | 909 | (246) |
| Foreign governments | 830 | (205) | 738 | (309) | 1,568 | (514) |
| Corporate | 19,530 | (673) | 44,051 | (10,997) | 63,581 | (11,670) |
| CLO | 2,675 | (48) | 2,325 | (215) | 5,000 | (263) |
| ABS | 9,361 | (155) | 4,070 | (309) | 13,431 | (464) |
| CMBS | 1,868 | (56) | 1,773 | (315) | 3,641 | (371) |
| RMBS | 825 | (13) | 1,261 | (157) | 2,086 | (170) |
| Total AFS securities | 38,166 | (1,267) | 58,522 | (13,701) | 96,688 | (14,968) |
| AFS securities – related parties | ||||||
| Corporate | 499 | (9) | 446 | (47) | 945 | (56) |
| CLO | 586 | (10) | 544 | (56) | 1,130 | (66) |
| ABS | 2,533 | (43) | 3,355 | (235) | 5,888 | (278) |
| Total AFS securities – related parties | 3,618 | (62) | 4,345 | (338) | 7,963 | (400) |
| Total AFS securities, including related parties | $41,784 | $(1,329) | $62,867 | $(14,039) | $104,651 | $(15,368) |
The following summarizes the number of AFS securities that were in an unrealized loss position, including related parties, for which an allowance for credit losses has not been recorded:
| June 30, 2025 | ||
|---|---|---|
| Unrealized loss position | Unrealized loss position 12 months or more | |
| AFS securities | 6,857 | 5,525 |
| AFS securities – related parties | 165 | 68 |
The unrealized losses on AFS securities can primarily be attributed to changes in market interest rates since the application of pushdown accounting or acquisition. We did not recognize the unrealized losses in income, unless as required for hedge accounting, as we intend to hold these securities and it is not more likely than not we will be required to sell a security before the recovery of its amortized cost.
Allowance for Credit Losses—The following table summarizes the activity in the allowance for credit losses for AFS securities by asset type:
| Three months ended June 30, 2025 | |||||
|---|---|---|---|---|---|
| Additions · Reductions | |||||
| (In millions) | Beginning balance | Initial credit losses | Securities sold during the period | Additions (reductions) to previously impaired securities | Ending balance |
| AFS securities | |||||
| Corporate | $174 | $— | $— | $— | $174 |
| ABS | 82 | 39 | (2) | 11 | 130 |
| CMBS | 60 | — | — | 2 | 62 |
| RMBS | 392 | 3 | (3) | 2 | 394 |
| Total AFS securities | 708 | 42 | (5) | 15 | 760 |
| AFS securities – related parties, ABS | 1 | — | — | — | 1 |
| Total AFS securities, including related parties | $709 | $42 | $(5) | $15 | $761 |
| Three months ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| Additions · Reductions | |||||
| (In millions) | Beginning balance | Initial credit losses | Securities sold during the period | Additions (reductions) to previously impaired securities | Ending balance |
| AFS securities | |||||
| Corporate | $127 | $41 | $— | $— | $168 |
| CLO | 1 | — | — | (1) | — |
| ABS | 51 | 10 | (1) | 7 | 67 |
| CMBS | 31 | 25 | — | 1 | 57 |
| RMBS | 387 | 1 | (6) | (4) | 378 |
| Total AFS securities | 597 | 77 | (7) | 3 | 670 |
| AFS securities – related parties, ABS | 1 | — | — | — | 1 |
| Total AFS securities, including related parties | $598 | $77 | $(7) | $3 | $671 |
| Six months ended June 30, 2025 | |||||
|---|---|---|---|---|---|
| Additions · Reductions | |||||
| (In millions) | Beginning balance | Initial credit losses | Securities sold during the period | Additions (reductions) to previously impaired securities | Ending balance |
| AFS securities | |||||
| Corporate | $175 | $— | $— | $(1) | $174 |
| ABS | 76 | 40 | (3) | 17 | 130 |
| CMBS | 60 | — | — | 2 | 62 |
| RMBS | 397 | 5 | (10) | 2 | 394 |
| Total AFS securities | 708 | 45 | (13) | 20 | 760 |
| AFS securities – related parties, ABS | 1 | — | — | — | 1 |
| Total AFS securities, including related parties | $709 | $45 | $(13) | $20 | $761 |
| Six months ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| Additions · Reductions | |||||
| (In millions) | Beginning balance | Initial credit losses | Securities sold during the period | Additions (reductions) to previously impaired securities | Ending balance |
| AFS securities | |||||
| Corporate | $129 | $48 | $(8) | $(1) | $168 |
| CLO | 2 | — | — | (2) | — |
| ABS | 49 | 12 | (1) | 7 | 67 |
| CMBS | 29 | 26 | — | 2 | 57 |
| RMBS | 381 | 5 | (10) | 2 | 378 |
| Total AFS securities | 590 | 91 | (19) | 8 | 670 |
| AFS securities – related parties, ABS | 1 | — | — | — | 1 |
| Total AFS securities, including related parties | $591 | $91 | $(19) | $8 | $671 |
Net Investment Income—Net investment income by asset class consists of the following:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| AFS securities | $2,884 | $2,340 | $5,555 | $4,477 |
| Trading securities | 66 | 44 | 108 | 85 |
| Equity securities | 29 | 29 | 44 | 46 |
| Mortgage loans | 1,262 | 890 | 2,385 | 1,704 |
| Investment funds | 129 | (17) | 169 | (6) |
| Funds withheld at interest | 244 | 359 | 509 | 722 |
| Other | 229 | 191 | 461 | 403 |
| Investment revenue | 4,843 | 3,836 | 9,231 | 7,431 |
| Investment expenses | (414) | (327) | (811) | (630) |
| Net investment income | $4,429 | $3,509 | $8,420 | $6,801 |
Investment Related Gains (Losses)—Investment related gains (losses) by asset class consists of the following:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Gross realized gains on investment activity | $1,522 | $125 | $2,233 | $192 |
| Gross realized losses on investment activity | (143) | (218) | (378) | (565) |
| Net realized investment gains (losses) on AFS securities | 1,379 | (93) | 1,855 | (373) |
| Net recognized investment gains (losses) on trading securities | 261 | (33) | 341 | (98) |
| Net recognized investment gains (losses) on equity securities | 36 | (12) | 51 | 27 |
| Net recognized investment gains (losses) on mortgage loans | 785 | 93 | 1,799 | (265) |
| Derivative gains (losses) | (1,075) | (553) | (2,587) | 878 |
| Provision for credit losses | (56) | (90) | (64) | (100) |
| Other gains (losses) | (1,335) | 554 | (2,228) | 1,474 |
| Investment related gains (losses) | $(5) | $(134) | $(833) | $1,543 |
| 1 Includes the effects of recognized gains or losses on AFS securities associated with designated hedges. | ||||
Proceeds from sales of AFS securities were $5,865 million and $7,048 million for the three months ended June 30, 2025 and 2024, respectively, and $14,810 million and $10,766 million for the six months ended June 30, 2025 and 2024, respectively.
The following table summarizes the change in unrealized gains (losses) on trading and equity securities we held as of the respective period end:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Trading securities | $118 | $(21) | $140 | $(41) |
| Equity securities | 27 | (8) | 39 | 24 |
Repurchase Agreements—The following table summarizes the remaining contractual maturities of our repurchase agreements, which are included in payables for collateral on derivatives and securities to repurchase on the condensed consolidated balance sheets:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Less than 30 days | $790 | $2,752 |
| 30 – 90 days | — | 300 |
| 91 days to 1 year | — | 1,095 |
| Greater than 1 year | 2,747 | 1,569 |
| Payables for repurchase agreements | $3,537 | $5,716 |
The following table summarizes the securities pledged as collateral for repurchase agreements:
| June 30, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| (In millions) | Amortized Cost | Fair Value | Amortized Cost | Fair Value |
| AFS securities | ||||
| US government and agencies | $711 | $514 | $3,253 | $2,693 |
| Foreign governments | 243 | 179 | 159 | 107 |
| Corporate | 2,113 | 1,894 | 1,877 | 1,573 |
| CLO | 585 | 588 | 587 | 588 |
| ABS | 598 | 561 | 596 | 552 |
| RMBS | — | — | 369 | 365 |
| Total securities pledged under repurchase agreements | $4,250 | $3,736 | $6,841 | $5,878 |
Reverse Repurchase Agreements—As of June 30, 2025 and December 31, 2024, amounts loaned under reverse repurchase agreements were $189 million and $935 million, respectively, and the fair value of the collateral, comprised primarily of asset-backed securities, was $1,034 million and $2,208 million, respectively.
Mortgage Loans, including related parties and consolidated VIEs—Mortgage loans include both commercial and residential loans. We have elected the fair value option on our mortgage loan portfolio. See Note 5 – Fair Value for further fair value option information. The following represents the mortgage loan portfolio, with fair value option loans presented at unpaid principal balance:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Commercial mortgage loans | $37,482 | $32,544 |
| Commercial mortgage loans under development | 1,782 | 1,987 |
| Total commercial mortgage loans | 39,264 | 34,531 |
| Mark to fair value | (1,997) | (2,099) |
| Commercial mortgage loans | 37,267 | 32,432 |
| Residential mortgage loans | 43,445 | 35,223 |
| Mark to fair value | 396 | (540) |
| Residential mortgage loans | 43,841 | 34,683 |
| Mortgage loans | $81,108 | $67,115 |
We invest in commercial mortgage loans, primarily on income-producing properties including office and retail buildings, apartments, hotels, and industrial properties. We diversify the commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. We evaluate mortgage loans based on relevant current information to confirm whether properties are performing at a consistent and acceptable level to secure the related debt.
The distribution of commercial mortgage loans, including those under development, by property type and geographic region, is as follows:
| June 30, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| (In millions, except percentages) | Fair Value | Percentage of Total | Fair Value | Percentage of Total |
| Property type | ||||
| Apartment | $14,559 | 39.1% | $11,746 | 36.2% |
| Industrial | 7,849 | 21.0% | 6,793 | 21.0% |
| Office building | 4,217 | 11.3% | 4,162 | 12.8% |
| Hotels | 2,864 | 7.7% | 2,786 | 8.6% |
| Retail | 2,422 | 6.5% | 2,269 | 7.0% |
| Other commercial | 5,356 | 14.4% | 4,676 | 14.4% |
| Total commercial mortgage loans | $37,267 | 100.0% | $32,432 | 100.0% |
| US region | ||||
| East North Central | $1,672 | 4.5% | $1,546 | 4.8% |
| East South Central | 430 | 1.2% | 438 | 1.3% |
| Middle Atlantic | 9,980 | 26.8% | 8,386 | 25.9% |
| Mountain | 1,544 | 4.2% | 1,322 | 4.1% |
| New England | 1,093 | 2.9% | 1,118 | 3.4% |
| Pacific | 6,386 | 17.1% | 5,768 | 17.8% |
| South Atlantic | 6,679 | 17.9% | 6,198 | 19.1% |
| West North Central | 308 | 0.8% | 221 | 0.7% |
| West South Central | 2,391 | 6.4% | 1,971 | 6.1% |
| Total US region | 30,483 | 81.8% | 26,968 | 83.2% |
| International region | ||||
| United Kingdom | 2,988 | 8.0% | 2,281 | 7.0% |
| Other international1 | 3,796 | 10.2% | 3,183 | 9.8% |
| Total international region | 6,784 | 18.2% | 5,464 | 16.8% |
| Total commercial mortgage loans | $37,267 | 100.0% | $32,432 | 100.0% |
| 1 Represents all other countries, with each individual country comprising less than 5% of the portfolio. | ||||
Our residential mortgage loan portfolio primarily consists of first lien residential mortgage loans collateralized by properties in various geographic locations and is summarized by proportion of the portfolio in the following table:
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| US States | ||
| California | 25.9% | 25.6% |
| Florida | 12.0% | 12.4% |
| Texas | 7.4% | 7.4% |
| Other1 | 46.5% | 45.5% |
| Total US residential mortgage loan percentage | 91.8% | 90.9% |
| International1 | 8.2% | 9.1% |
| Total residential mortgage loan percentage | 100.0% | 100.0% |
| 1 Represents all other states or countries, with each individual state or country comprising less than 5% of the portfolio. | ||
Investment Funds—Our investment fund portfolio strategy primarily focuses on core holdings of origination and retirement services platforms, equity and credit, and other funds. Origination platforms include investments sourced by affiliated platforms that originate loans to third parties and in which we gain exposure directly to the loan or indirectly through our ownership of the origination platform and/or securitizations of assets originated by the origination platform. Retirement services platforms include investments in equity of financial services companies. Our credit strategy comprises direct origination, asset-backed, multi-credit and opportunistic credit funds focused on generating excess returns through high-quality credit underwriting and origination. Our equity strategy comprises private equity, hybrid value, secondaries equity, real estate equity, impact investing, infrastructure and clean transition equity funds that raise capital from investors to pursue control-oriented investments across the universe of private assets. Our investment funds can meet the definition of a VIE, which are discussed further in Note 4 – Variable Interest Entities. Our investment funds do not specify timing of distributions on the funds’ underlying assets.
The following summarizes our investment funds, including related parties and consolidated VIEs:
| June 30, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| (In millions, except percentages) | Carrying value | Percentage of total | Carrying value | Percentage of total |
| Investment funds | ||||
| Equity | $102 | 0.5% | $107 | 0.5% |
| Investment funds – related parties | ||||
| Origination platforms | 31 | 0.1% | 29 | 0.2% |
| Retirement services platforms | 1,492 | 6.9% | 1,317 | 6.7% |
| Equity | 218 | 1.0% | 244 | 1.2% |
| Credit | 314 | 1.5% | 253 | 1.3% |
| Other | 7 | —% | 10 | 0.1% |
| Total investment funds – related parties | 2,062 | 9.5% | 1,853 | 9.5% |
| Investment funds – consolidated VIEs | ||||
| Origination platforms | 7,536 | 35.1% | 6,347 | 32.2% |
| Equity | 7,383 | 34.3% | 7,702 | 39.0% |
| Credit | 3,735 | 17.4% | 3,062 | 15.5% |
| Other | 694 | 3.2% | 654 | 3.3% |
| Total investment funds – consolidated VIEs | 19,348 | 90.0% | 17,765 | 90.0% |
| Total investment funds, including related parties and consolidated VIEs | $21,512 | 100.0% | $19,725 | 100.0% |
Non-Consolidated Securities and Investment Funds
Fixed maturity securities –We invest in securitization entities as a debt holder or an investor in the residual interest of the securitization vehicle. These entities are deemed VIEs due to insufficient equity within the structure and lack of control by the equity investors over the activities that significantly impact the economics of the entity. In general, we are a debt investor within these entities and, as such, hold a variable interest; however, due to the debt holders’ lack of ability to control the decisions within the structure that significantly impact the entity, and the fact the debt holders are protected from losses due to the subordination of the equity tranche, the debt holders are not deemed the primary beneficiary. Securitization vehicles in which we hold the residual tranche are not consolidated because we do not unilaterally have substantive rights to remove the general partner, or when assessing related party interests, we are not under common control, as defined by US GAAP, with the related parties, nor are substantially all of the activities conducted on our behalf; therefore, we are not deemed the primary beneficiary. Debt investments and investments in the residual tranche of securitization entities are considered debt instruments and are held at fair value and classified as AFS or trading securities on the condensed consolidated balance sheets.
Investment funds –Investment funds include non-fixed income, alternative investments in the form of limited partnerships or similar legal structures.
Equity securities – We invest in preferred equity securities issued by entities deemed to be VIEs due to insufficient equity within the structure.
Our risk of loss associated with our non-consolidated investments depends on the investment. Investment funds, equity securities and trading securities are limited to the carrying value plus unfunded commitments. AFS securities are limited to amortized cost plus unfunded commitments.
The following summarizes the carrying value and maximum loss exposure of these non-consolidated investments:
| June 30, 2025 | December 31, 2024 | |||
|---|---|---|---|---|
| (In millions) | Carrying Value | Maximum Loss Exposure | Carrying Value | Maximum Loss Exposure |
| Investment funds | $102 | $745 | $107 | $987 |
| Investment in related parties – investment funds | 2,062 | 3,119 | 1,853 | 3,226 |
| Assets of consolidated VIEs – investment funds | 19,348 | 25,691 | 17,765 | 23,597 |
| Investment in fixed maturity securities | 83,063 | 83,542 | 72,523 | 74,797 |
| Investment in related parties – fixed maturity securities | 19,746 | 22,521 | 17,239 | 21,793 |
| Investment in related parties – equity securities | 266 | 315 | 234 | 234 |
| Total non-consolidated investments | $124,587 | $135,933 | $109,721 | $124,634 |
Concentrations—The following table represents our investment concentrations in excess of 10% of AHL stockholders’ equity:
| (In millions) | June 30, 2025 |
|---|---|
| AP Grange Holdings, LLC1 | $4,773 |
| Atlas Securitized Products Holdings LP (Atlas)2 | 3,732 |
| Fox Hedge L.P.1 | 3,175 |
| Investment-grade debt issued by Blackstone Private Credit Fund3 | 2,021 |
| December 31, 2024 | |
| AP Grange Holdings, LLC1 | $4,661 |
| Atlas2 | 3,172 |
| Fox Hedge L.P.1 | 2,924 |
| 1 Investment-grade ABS. | |
| 2 See Note 11 – Related Parties for additional details on Atlas. Amounts are representative of single issuer risk and may only include a portion of the total investments associated with a related party. | |
| 3 Senior unsecured investment-grade debt issued by a non-exchange traded business development company. | |
- Derivative Instruments
We use a variety of derivative instruments to manage risks, primarily equity, interest rate, foreign currency and market volatility. See Note 5 – Fair Value for information about the fair value hierarchy for derivatives.
The following table presents the notional amount and fair value of derivative instruments:
| June 30, 2025 · December 31, 2024 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Notional Amount · Fair Value · Notional Amount · Fair Value | ||||||||||
| (In millions) · Assets · Liabilities · Assets · Liabilities | ||||||||||
| Derivatives designated as hedges | ||||||||||
| Foreign currency hedges | ||||||||||
| Swaps | 20,404 | $623 | $964 | 15,669 | $938 | $211 | ||||
| Forwards | 2,721 | 60 | 49 | 3,139 | 331 | 5 | ||||
| Interest rate swaps | 4,382 | 102 | 247 | 4,506 | — | 654 | ||||
| Forwards on net investments | 224 | — | 15 | 218 | 11 | — | ||||
| Interest rate swaps | 29,423 | 142 | 41 | 24,885 | 55 | 138 | ||||
| Total derivatives designated as hedges | 927 | 1,316 | 1,335 | 1,008 | ||||||
| Derivatives not designated as hedges | ||||||||||
| Equity options | 91,009 | 5,069 | 146 | 85,452 | 5,002 | 126 | ||||
| Futures | 59 | 133 | — | 37 | 93 | 11 | ||||
| Foreign currency swaps | 18,216 | 185 | 1,064 | 14,908 | 600 | 199 | ||||
| Interest rate swaps and forwards | 3,249 | 63 | 252 | 3,255 | 67 | 124 | ||||
| Other swaps | 2,066 | 12 | — | 2,644 | 3 | 5 | ||||
| Foreign currency forwards | 39,990 | 512 | 2,111 | 39,598 | 1,054 | 2,083 | ||||
| Embedded derivatives | ||||||||||
| Funds withheld, including related parties | (3,221) | 60 | (3,650) | 4 | ||||||
| Interest sensitive contract liabilities | — | 12,276 | — | 11,242 | ||||||
| Total derivatives not designated as hedges | 2,753 | 15,909 | 3,169 | 13,794 | ||||||
| Total derivatives | $3,680 | $17,225 | $4,504 | $14,802 | ||||||
Derivatives Designated as Hedges
Cash Flow Hedges – We use interest rate swaps to convert floating-rate interest payments to fixed-rate interest payments to reduce exposure to interest rate changes. The interest rate swaps will expire by May 2035. During the three months ended June 30, 2025 and 2024, we recognized gains of $76 million and $18 million, respectively, in other comprehensive income (OCI) associated with these hedges. During the six months ended June 30, 2025 and 2024, we recognized gains of $172 million and losses of $3 million, respectively, in OCI associated with these hedges. There wereno amounts deemed ineffective during the three and six months ended June 30, 2025 and 2024. As of June 30, 2025, no amounts were expected to be reclassified to income within the next 12 months.
Fair Value Hedges – We use foreign currency forward contracts, foreign currency swaps, foreign currency interest rate swaps and interest rate swaps that are designated and accounted for as fair value hedges to hedge certain exposures to foreign currency risk and interest rate risk. The foreign currency forward price is agreed upon at the time of the contract and payment is made at a specified future date. The amortized cost of AFS debt securities in qualifying fair value hedges of foreign currency risk was $17,818 million and $16,307 million as of June 30, 2025 and December 31, 2024, respectively. The carrying value of interest sensitive contract liabilities in qualifying fair value hedges of foreign currency swaps was $6,012 million and $2,426 million as of June 30, 2025 and December 31, 2024, respectively.
The following represents the carrying amount and the cumulative fair value of hedging adjustments of hedged liabilities, excluding those solely hedging foreign currency risk:
| June 30, 2025 · December 31, 2024 | ||||
|---|---|---|---|---|
| (In millions) | Carrying amount of the hedged liabilities | Cumulative amount of fair value hedging gains (losses)1 | Carrying amount of the hedged liabilities | Cumulative amount of fair value hedging gains (losses) |
| Interest sensitive contract liabilities | ||||
| Foreign currency interest rate swaps | $4,315 | $85 | $3,946 | $488 |
| Interest rate swaps | 17,327 | (34) | 17,873 | 130 |
| 1 Excludes gains (losses) related to foreign currency risk. | ||||
The following is a summary of the gains (losses) related to the derivatives and related hedged items in fair value hedge relationships:
| Amounts excluded | |||||
|---|---|---|---|---|---|
| (In millions) | Derivatives | Hedged items | Net | Recognized in income through amortization approach | Recognized in income through changes in fair value |
| Investment related gains (losses) | |||||
| Foreign currency forwards | $(235) | $228 | $(7) | $9 | $— |
| Foreign currency swaps | (681) | 699 | 18 | — | — |
| Foreign currency interest rate swaps | 344 | (330) | 14 | — | — |
| Interest rate swaps | 65 | (49) | 16 | — | — |
| Interest sensitive contract benefits | |||||
| Foreign currency interest rate swaps | 25 | (24) | 1 | — | — |
| Investment related gains (losses) | |||||
| Foreign currency forwards | $43 | $(51) | $(8) | $13 | $(3) |
| Foreign currency swaps | 43 | (24) | 19 | — | — |
| Foreign currency interest rate swaps | (7) | 6 | (1) | — | — |
| Interest rate swaps | (9) | 1 | (8) | — | — |
| Interest sensitive contract benefits | |||||
| Foreign currency interest rate swaps | 24 | (23) | 1 | — | — |
| Amounts excluded | |||||
|---|---|---|---|---|---|
| (In millions) | Derivatives | Hedged items | Net | Recognized in income through amortization approach | Recognized in income through changes in fair value |
| Investment related gains (losses) | |||||
| Foreign currency forwards | $(350) | $332 | $(18) | $19 | $— |
| Foreign currency swaps | (1,013) | 1,058 | 45 | — | — |
| Foreign currency interest rate swaps | 481 | (464) | 17 | — | — |
| Interest rate swaps | 194 | (174) | 20 | — | — |
| Interest sensitive contract benefits | |||||
| Foreign currency interest rate swaps | 48 | (47) | 1 | — | — |
| Investment related gains (losses) | |||||
| Foreign currency forwards | $179 | $(183) | $(4) | $31 | $6 |
| Foreign currency swaps | 155 | (138) | 17 | — | — |
| Foreign currency interest rate swaps | (123) | 123 | — | — | — |
| Interest rate swaps | (115) | 76 | (39) | — | — |
| Interest sensitive contract benefits | |||||
| Foreign currency interest rate swaps | 40 | (39) | 1 | — | — |
The following is a summary of the gains (losses) excluded from the assessment of hedge effectiveness that were recognized in OCI:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Foreign currency forwards | $3 | $2 | $29 | $(15) |
| Foreign currency swaps | (87) | 64 | 20 | 26 |
Net Investment Hedges – We use foreign currency forwards to hedge the foreign currency exchange rate risk of our investments in subsidiaries that have a reporting currency other than the US dollar. We assess hedge effectiveness based on the changes in forward rates. During the three months ended June 30, 2025 and 2024, these derivatives had losses of $14 million and $0 million, respectively. During the six months ended June 30, 2025 and 2024, these derivatives had losses of $22 million and gains of $3 million, respectively. These derivatives are included in foreign currency translation and other adjustments on the condensed consolidated statements of comprehensive income (loss). As of June 30, 2025 and December 31, 2024, the cumulative foreign currency translations recorded in AOCI related to these net investment hedges were gains of $7 million and $29 million, respectively. During the three and six months ended June 30, 2025 and 2024, there wereno amounts deemed ineffective.
Derivatives Not Designated as Hedges
Equity options – We use equity indexed options to economically hedge fixed indexed annuity products that guarantee the return of principal to the policyholder and credit interest based on a percentage of the gain in a specified market index, including the S&P 500 and other bespoke indices. To hedge against adverse changes in equity indices, we enter into contracts to buy equity indexed options. The contracts are net settled in cash based on differentials in the indices at the time of exercise and the strike price.
Futures – Futures contracts are purchased to hedge the growth in interest credited to the customer as a direct result of increases in the related indices. We enter into exchange-traded futures with regulated futures commission clearing brokers who are members of a trading exchange. Under exchange-traded futures contracts, we agree to purchase a specified number of contracts with other parties and to post variation margin on a daily basis in an amount equal to the difference in the daily fair values of those contracts.
Interest rate swaps and forwards –We use interest rate swaps and forwards to reduce market risks from interest rate changes and to alter interest rate exposure arising from duration mismatches between assets and liabilities. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed-upon notional principal amount at specified intervals.
Other swaps – Other swaps include total return swaps, credit default swaps and swaptions. We purchase total rate of return swaps to gain exposure and benefit from a reference asset or index without ownership. Credit default swaps provide a measure of protection against the default of an issuer or allow us to gain credit exposure to an issuer or traded index. We use credit default swaps coupled with a bond to synthetically create the characteristics of a reference bond. Swaptions provide an option to enter into an interest rate swap and are used to hedge against interest rate exposure.
Embedded derivatives – We have embedded derivatives which are required to be separated from their host contracts and reported as derivatives. Host contracts include reinsurance agreements structured on a modco or funds withheld basis and indexed annuity products.
The following is a summary of the gains (losses) related to derivatives not designated as hedges:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Equity options | $871 | $105 | $(65) | $1,702 |
| Futures | (9) | (1) | (16) | 126 |
| Interest rate swaps and forwards and other swaps | (1,079) | (69) | (1,425) | (30) |
| Foreign currency forwards | (401) | (556) | (611) | (866) |
| Embedded derivatives on funds withheld | 41 | (112) | 199 | (187) |
| Amounts recognized in investment related gains (losses) | (577) | (633) | (1,918) | 745 |
| Embedded derivatives in indexed annuity products1 | (887) | 182 | 116 | (995) |
| Total gains (losses) on derivatives not designated as hedges | $(1,464) | $(451) | $(1,802) | $(250) |
| 1 Included in interest sensitive contract benefits on the condensed consolidated statements of income. | ||||
Credit Risk—We may be exposed to credit-related losses in the event of counterparty nonperformance on derivative financial instruments. Generally, the current credit exposure of our derivative contracts is the fair value at the reporting date less any collateral received from the counterparty.
We manage credit risk related to over-the-counter derivatives by entering into transactions with creditworthy counterparties. Where possible, we maintain collateral arrangements and use master netting agreements that provide for a single net payment from one counterparty to another at each due date and upon termination. We have also established counterparty exposure limits, where possible, in order to evaluate if there is sufficient collateral to support the net exposure.
Collateral arrangements typically require the posting of collateral in connection with its derivative instruments. Collateral agreements often contain posting thresholds, some of which may vary depending on the posting party’s financial strength ratings. Additionally, a decrease in our financial strength rating to a specified level can result in settlement of the derivative position.
The estimated fair value of our net derivative and other financial assets and liabilities after the application of master netting agreements and collateral were as follows:
| Gross amounts not offset on the condensed consolidated balance sheets | ||||||
|---|---|---|---|---|---|---|
| (In millions) | Gross amount recognized1 | Financial instruments2 | Collateral (received)/pledged | Net amount | Off-balance sheet securities collateral3 | Net amount after securities collateral |
| Derivative assets | $6,901 | $(2,496) | $(3,685) | $720 | $(536) | $184 |
| Derivative liabilities | (4,889) | 2,496 | 2,041 | (352) | 209 | (143) |
| Derivative assets | $8,154 | $(2,209) | $(5,922) | $23 | $— | $23 |
| Derivative liabilities | (3,556) | 2,209 | 1,333 | (14) | 2 | (12) |
| 1 The gross amounts of recognized derivative assets and derivative liabilities are reported on the condensed consolidated balance sheets. As of June 30, 2025 and December 31, 2024, amounts not subject to master netting or similar agreements were immaterial. | ||||||
| 2 Represents amounts offsetting derivative assets and derivative liabilities that are subject to an enforceable master netting agreement or similar agreement that are not netted against the gross derivative assets or gross derivative liabilities for presentation on the condensed consolidated balance sheets. | ||||||
| 3 For non-cash collateral received, we do not recognize the collateral on our balance sheet unless the obligor (transferor) has defaulted under the terms of the secured contract and is no longer entitled to redeem the pledged asset. Amounts do not include any excess of collateral pledged or received. | ||||||
- Variable Interest Entities
We determined that we are required to consolidate certain Apollo-managed investment funds and other Apollo-managed structures. Since the criteria for the primary beneficiary are satisfied by our related party group, we are deemed the primary beneficiary. In addition, we consolidate certain securitization entities where we are deemed the primary beneficiary. No arrangement exists requiring us to provide additional funding in excess of our committed capital investment, liquidity, or the funding of losses or an increase to our loss exposure in excess of our investment in any of the consolidated VIEs.
The following summarizes the income statement activity of the consolidated VIEs:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Trading securities | $54 | $30 | $101 | $65 |
| Mortgage loans | 38 | 31 | 81 | 61 |
| Investment funds | 20 | — | 21 | 21 |
| Other | (32) | (5) | (46) | (14) |
| Net investment income | $80 | $56 | $157 | $133 |
| Net recognized investment gains (losses) on trading securities | $4 | $(8) | $6 | $(8) |
| Net recognized investment gains (losses) on mortgage loans | (13) | (2) | 7 | (28) |
| Net recognized investment gains on investment funds | 461 | 321 | 988 | 685 |
| Other gains (losses) | 16 | (5) | 17 | (9) |
| Investment related gains (losses) | $468 | $306 | $1,018 | $640 |
- Fair Value
Fair value is the price we would receive to sell an asset or pay to transfer a liability (exit price) in an orderly transaction between market participants. We determine fair value based on the following fair value hierarchy:
Level 1 – Unadjusted quoted prices for identical assets or liabilities in an active market.
Level 2 – Quoted prices for inactive markets or valuation techniques that require observable direct or indirect inputs for substantially the full term of the asset or liability. Level 2 inputs include the following:
Quoted prices for similar assets or liabilities in active markets,
Observable inputs other than quoted market prices, and
Observable inputs derived principally from market data through correlation or other means.
Level 3 – Prices or valuation techniques with unobservable inputs significant to the overall fair value estimate. These valuations use critical assumptions not readily available to market participants. Level 3 valuations are based on market standard valuation methodologies, including discounted cash flows, matrix pricing or other similar techniques.
Net Asset Value (NAV) – Investment funds are typically measured using NAV as a practical expedient in determining fair value and are not classified in the fair value hierarchy. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the investment fund financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the investment funds may have significant unobservable inputs, which may include but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model.
The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the instrument’s fair value measurement.
We use a number of valuation sources to determine fair values. Valuation sources can include quoted market prices; third-party commercial pricing services; third-party brokers; industry-standard, vendor modeling software that uses market observable inputs; and other internal modeling techniques based on projected cash flows. We periodically review the assumptions and inputs of third-party commercial pricing services through internal valuation price variance reviews, comparisons to internal pricing models, back testing to recent trades, or monitoring trading volumes.
The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis:
| June 30, 2025 | |||||
|---|---|---|---|---|---|
| (In millions) | Total | NAV | Level 1 | Level 2 | Level 3 |
| Assets | |||||
| AFS securities | |||||
| US government and agencies | $9,023 | $— | $9,023 | $— | $— |
| US state, municipal and political subdivisions | 840 | — | — | 840 | — |
| Foreign governments | 1,752 | — | 622 | 1,107 | 23 |
| Corporate | 94,563 | — | 9 | 87,162 | 7,392 |
| CLO | 31,388 | — | — | 31,388 | — |
| ABS | 27,362 | — | — | 13,218 | 14,144 |
| CMBS | 13,500 | — | — | 13,500 | — |
| RMBS | 10,322 | — | — | 9,824 | 498 |
| Total AFS securities | 188,750 | — | 9,654 | 157,039 | 22,057 |
| Trading securities | 4,060 | — | 24 | 4,018 | 18 |
| Equity securities | 1,150 | — | 182 | 960 | 8 |
| Mortgage loans | 77,289 | — | — | — | 77,289 |
| Funds withheld at interest – embedded derivative | (2,743) | — | — | — | (2,743) |
| Derivative assets | 6,901 | — | 149 | 6,751 | 1 |
| Short-term investments | 16 | — | — | 4 | 12 |
| Other investments | 1,695 | — | — | 954 | 741 |
| Cash and cash equivalents | 10,329 | — | 10,329 | — | — |
| Restricted cash | 1,720 | — | 1,720 | — | — |
| Investments in related parties | |||||
| AFS securities | |||||
| Corporate | 2,569 | — | — | 1,093 | 1,476 |
| CLO | 7,538 | — | — | 6,468 | 1,070 |
| ABS | 11,809 | — | — | 999 | 10,810 |
| Total AFS securities – related parties | 21,916 | — | — | 8,560 | 13,356 |
| Trading securities | 399 | — | — | — | 399 |
| Equity securities | 266 | — | — | — | 266 |
| Mortgage loans | 1,275 | — | — | — | 1,275 |
| Investment funds | 1,297 | — | — | — | 1,297 |
| Funds withheld at interest – embedded derivative | (478) | — | — | — | (478) |
| Other investments | 339 | — | — | — | 339 |
| Reinsurance recoverable | 1,780 | — | — | — | 1,780 |
| Other assets | 277 | — | — | — | 277 |
| Assets of consolidated VIEs | |||||
| Trading securities | 3,265 | — | — | 927 | 2,338 |
| Mortgage loans | 2,544 | — | — | — | 2,544 |
| Investment funds | 19,348 | 19,078 | — | — | 270 |
| Other investments | 383 | — | 5 | 12 | 366 |
| Cash and cash equivalents | 191 | — | 191 | — | — |
| Total assets measured at fair value | $341,969 | $19,078 | $22,254 | $179,225 | $121,412 |
| Liabilities | |||||
| Interest sensitive contract liabilities | |||||
| Embedded derivative | $12,276 | $— | $— | $— | $12,276 |
| Universal life benefits | 755 | — | — | — | 755 |
| Future policy benefits | |||||
| AmerUs Life Insurance Company (AmerUs) Closed Block | 1,097 | — | — | — | 1,097 |
| Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits | 556 | — | — | — | 556 |
| Market risk benefits | 4,489 | — | — | — | 4,489 |
| Derivative liabilities | 4,889 | — | 10 | 4,879 | — |
| Other liabilities | 295 | — | — | — | 295 |
| Total liabilities measured at fair value | $24,357 | $— | $10 | $4,879 | $19,468 |
| December 31, 2024 | |||||
|---|---|---|---|---|---|
| (In millions) | Total | NAV | Level 1 | Level 2 | Level 3 |
| Assets | |||||
| AFS securities | |||||
| US government and agencies | $7,151 | $— | $7,149 | $2 | $— |
| US state, municipal and political subdivisions | 921 | — | — | 921 | — |
| Foreign governments | 1,568 | — | 658 | 881 | 29 |
| Corporate | 83,585 | — | 11 | 79,253 | 4,321 |
| CLO | 29,182 | — | — | 29,182 | — |
| ABS | 24,201 | — | — | 7,672 | 16,529 |
| CMBS | 10,741 | — | — | 10,741 | — |
| RMBS | 8,015 | — | — | 7,759 | 256 |
| Total AFS securities | 165,364 | — | 7,818 | 136,411 | 21,135 |
| Trading securities | 1,583 | — | 22 | 1,539 | 22 |
| Equity securities | 1,290 | — | 190 | 1,073 | 27 |
| Mortgage loans | 63,239 | — | — | — | 63,239 |
| Funds withheld at interest – embedded derivative | (3,035) | — | — | — | (3,035) |
| Derivative assets | 8,154 | — | 121 | 8,032 | 1 |
| Short-term investments | 255 | — | — | 86 | 169 |
| Other investments | 1,606 | — | — | 711 | 895 |
| Cash and cash equivalents | 12,733 | — | 12,733 | — | — |
| Restricted cash | 943 | — | 943 | — | — |
| Investments in related parties | |||||
| AFS securities | |||||
| Corporate | 2,461 | — | — | 1,029 | 1,432 |
| CLO | 6,035 | — | — | 5,339 | 696 |
| ABS | 10,631 | — | — | 890 | 9,741 |
| Total AFS securities – related parties | 19,127 | — | — | 7,258 | 11,869 |
| Trading securities | 573 | — | — | — | 573 |
| Equity securities | 234 | — | — | — | 234 |
| Mortgage loans | 1,297 | — | — | — | 1,297 |
| Investment funds | 1,139 | — | — | — | 1,139 |
| Funds withheld at interest – embedded derivative | (615) | — | — | — | (615) |
| Other investments | 331 | — | — | — | 331 |
| Reinsurance recoverable | 1,661 | — | — | — | 1,661 |
| Other assets | 313 | — | — | — | 313 |
| Assets of consolidated VIEs | |||||
| Trading securities | 2,301 | — | — | 347 | 1,954 |
| Mortgage loans | 2,579 | — | — | — | 2,579 |
| Investment funds | 17,765 | 16,995 | — | — | 770 |
| Other investments | 107 | — | 4 | — | 103 |
| Cash and cash equivalents | 583 | — | 583 | — | — |
| Total assets measured at fair value | $299,527 | $16,995 | $22,414 | $155,457 | $104,661 |
| Liabilities | |||||
| Interest sensitive contract liabilities | |||||
| Embedded derivative | $11,242 | $— | $— | $— | $11,242 |
| Universal life benefits | 742 | — | — | — | 742 |
| Future policy benefits | |||||
| AmerUs Closed Block | 1,102 | — | — | — | 1,102 |
| ILICO Closed Block and life benefits | 538 | — | — | — | 538 |
| Market risk benefits | 4,028 | — | — | — | 4,028 |
| Derivative liabilities | 3,556 | — | 19 | 3,536 | 1 |
| Other liabilities | 225 | — | — | — | 225 |
| Total liabilities measured at fair value | $21,433 | $— | $19 | $3,536 | $17,878 |
Fair Value Valuation Methods—We used the following valuation methods and assumptions to estimate fair value:
AFS and trading securities – We obtain the fair value for most marketable securities without an active market from several commercial pricing services. These are classified as Level 2 assets. The pricing services incorporate a variety of market observable information in their valuation techniques, including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data. This category typically includes US and non-US corporate bonds, US agency and government guaranteed securities, CLO, ABS, CMBS and RMBS.
We also have fixed maturity securities priced based on indicative broker quotes or by employing market accepted valuation models. For certain fixed maturity securities, the valuation model uses significant unobservable inputs and these are included in Level 3 in our fair value hierarchy. Significant unobservable inputs used include: discount rates, issue-specific credit adjustments, material non-public financial information, estimation of future earnings and cash flows, default rate assumptions, liquidity assumptions and indicative quotes from market makers.
We value privately placed fixed maturity securities based on the credit quality and duration of comparable marketable securities, which may be securities of another issuer with similar characteristics. In some instances, we use a matrix-based pricing model. These models consider the current level of risk-free interest rates, corporate spreads, credit quality of the issuer and cash flow characteristics of the security. We also consider additional factors such as net worth of the borrower, value of collateral, capital structure of the borrower, presence of guarantees and our evaluation of the borrower’s ability to compete in its relevant market. Privately placed fixed maturity securities are classified as Level 2 or 3.
Equity securities – Fair values of publicly traded equity securities are based on quoted market prices and classified as Level 1. Other equity securities, typically private equities or equity securities not traded on an exchange, we value based on other sources, such as commercial pricing services or brokers, and are classified as Level 2 or 3.
Mortgage loans – We estimate fair value on a monthly basis using discounted cash flow analysis and rates being offered for similar loans to borrowers with similar credit ratings. Loans with similar characteristics are aggregated for purposes of the calculations. The discounted cash flow model uses unobservable inputs, including estimates of discount rates and loan prepayments. Mortgage loans are classified as Level 3.
Investment funds – Certain investment funds for which we elected the fair value option are included in Level 3 and are priced based on market accepted valuation models. The valuation models use significant unobservable inputs, which include material non-public financial information, estimation of future distributable earnings and demographic assumptions.
Other investments – The fair values of other investments are primarily determined using a discounted cash flow model using discount rates for similar investments.
Funds withheld at interest embedded derivatives – Funds withheld at interest embedded derivatives represent the right to receive or obligation to pay the total return on the assets supporting the funds withheld at interest or funds withheld liability, respectively, and are analogous to a total return swap with a floating rate leg. The fair value of embedded derivatives on funds withheld and modco agreements is measured as the unrealized gain (loss) on the underlying assets and classified as Level 3.
Derivatives – Derivative contracts can be exchange-traded or over-the-counter. Exchange-traded derivatives typically fall within Level 1 of the fair value hierarchy depending on trading activity. Over-the-counter derivatives are valued using valuation models or an income approach using third-party broker valuations. Valuation models require a variety of inputs, including contractual terms, market prices, yield curves, credit curves, measures of volatility, prepayment rates and correlation of the inputs. We consider and incorporate counterparty credit risk in the valuation process through counterparty credit rating requirements and monitoring of overall exposure. We also evaluate and include our own nonperformance risk in valuing derivatives. The majority of our derivatives trade in liquid markets; therefore, we can verify model inputs and model selection does not involve significant management judgment. These are typically classified within Level 2 of the fair value hierarchy.
Cash and cash equivalents, including restricted cash –The carrying amount for cash equals fair value. We estimate the fair value for cash equivalents based on quoted market prices. These assets are classified as Level 1.
Other assets and market risk benefits liability –Other assets at fair value consist of market risk benefit assets. See Note 7 – Long-duration Contracts for additional information on market risk benefits valuation methodology and additional fair value disclosures. Market risk benefits are classified as Level 3.
Interest sensitive contract liabilities embedded derivatives – Embedded derivatives related to interest sensitive contract liabilities with fixed indexed annuity products are classified as Level 3. The valuations include significant unobservable inputs associated with economic assumptions and actuarial assumptions for policyholder behavior.
AmerUs Closed Block – We elected the fair value option for the future policy benefits liability in the AmerUs Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component is the present value of the projected release of required capital and future earnings before income taxes on required capital supporting the AmerUs Closed Block, discounted at a rate which represents a market participant’s required rate of return, less the initial required capital. Unobservable inputs include estimates for these items. The AmerUs Closed Block policyholder liabilities and any corresponding reinsurance recoverable are classified as Level 3.
ILICO Closed Block – We elected the fair value option for the ILICO Closed Block. Our valuation technique is to set the fair value of policyholder liabilities equal to the fair value of assets. There is an additional component which captures the fair value of the open block’s obligations to the closed block business. This component uses the present value of future cash flows which include commissions, administrative expenses, reinsurance premiums and benefits, and an explicit cost of capital. The discount rate includes a margin to reflect the business and nonperformance risk. Unobservable inputs include estimates for these items. The ILICO Closed Block policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3.
Universal life liabilities and other life benefits – We elected the fair value option for certain blocks of universal and other life business ceded to Global Atlantic. We use a present value of liability cash flows. Unobservable inputs include estimates of mortality, persistency, expenses, premium payments and a risk margin used in the discount rates that reflect the riskiness of the business. These universal life policyholder liabilities and corresponding reinsurance recoverable are classified as Level 3.
Other liabilities –Other liabilities include funds withheld liability embedded derivatives, as described above in funds withheld at interest embedded derivatives, and a ceded modco agreement of certain inforce funding agreement contracts for which we elected the fair value option. We estimate the fair value of the ceded modco agreement by discounting projected cash flows for net settlements and certain periodic and non-periodic payments. Unobservable inputs include estimates for asset portfolio returns and economic inputs used in the discount rate, including risk margin. Depending on the projected cash flows and other assumptions, the contract may be recorded as an asset or liability. The estimate is classified as Level 3.
Fair Value Option—The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Trading securities | $261 | $(40) | $336 | $(100) |
| Mortgage loans | 892 | 82 | 1,933 | (318) |
| Investment funds | 120 | 5 | 203 | (19) |
| Future policy benefits | 10 | 31 | 5 | 58 |
| Other | (29) | (11) | (17) | 4 |
| Total gains (losses) | $1,254 | $67 | $2,460 | $(375) |
Gains and losses on trading securities, mortgage loans, investments of consolidated VIEs, and other are recorded in investment related gains (losses) on thecondensed consolidated statements of income. Gains and losses related to investment funds are recorded in net investment income on the condensed consolidated statements of income. We record the change in fair value of future policy benefits in future policy and other policy benefits on the condensed consolidated statements of income.
The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Unpaid principal balance | $82,709 | $69,754 |
| Mark to fair value | (1,601) | (2,639) |
| Fair value | $81,108 | $67,115 |
The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status | $614 | $195 |
| Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status | (257) | (102) |
| Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status | $357 | $93 |
| Fair value of commercial mortgage loans 90 days or more past due | $108 | $31 |
| Fair value of commercial mortgage loans in non-accrual status | 357 | 93 |
The following represents our residential mortgage loan portfolio 90 days or more past due and/or in non-accrual status:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status | $743 | $898 |
| Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status | (69) | (51) |
| Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status | $674 | $847 |
| Fair value of residential mortgage loans 90 days or more past due1 | $674 | $847 |
| Fair value of residential mortgage loans in non-accrual status | 611 | 765 |
| 1 As of June 30, 2025 and December 31, 2024 includes $63 million and $82 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies. | ||
The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Mortgage loans | $(20) | $3 | $(23) | $(30) |
We estimated the portion of gains and losses attributable to changes in instrument-specific credit risk by identifying commercial mortgage loans with loan-to-value ratios meeting credit quality criteria, and residential mortgage loans with delinquency status meeting credit quality criteria.
Level 3 Financial Instruments—The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability ofpricing sources, as described in the valuation methods above.
| Three months ended June 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total realized and unrealized gains (losses) | ||||||||
| (In millions) | Beginning balance | Included in income | Included in OCI | Net purchases, issuances, sales and settlements | Net transfers in (out) | Ending balance | Total gains (losses) included in earnings1 | Total gains (losses) included in OCI1 |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $28 | $— | $— | $(5) | $— | $23 | $— | $— |
| Corporate | 5,605 | 56 | 51 | 1,680 | — | 7,392 | 51 | 59 |
| ABS | 12,572 | (17) | 306 | 1,926 | (643) | 14,144 | 3 | 321 |
| CMBS | — | 1 | (1) | — | — | — | — | — |
| RMBS | 306 | 5 | 2 | 234 | (49) | 498 | — | 1 |
| Trading securities | 7 | — | — | 11 | — | 18 | (6) | — |
| Equity securities | 26 | — | — | (18) | — | 8 | — | — |
| Mortgage loans | 70,916 | 772 | — | 5,601 | — | 77,289 | 821 | — |
| Funds withheld at interest – embedded derivative | (2,847) | 104 | — | — | — | (2,743) | — | — |
| Derivative assets | 1 | — | — | — | — | 1 | — | — |
| Short-term investments | 48 | — | — | (36) | — | 12 | — | — |
| Other investments | 896 | 1 | — | (156) | — | 741 | (1) | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 1,435 | 7 | 33 | 1 | — | 1,476 | — | 32 |
| CLO | 1,070 | — | — | — | — | 1,070 | — | — |
| ABS | 10,385 | 2 | 31 | 407 | (15) | 10,810 | — | 26 |
| Trading securities | 437 | — | — | (38) | — | 399 | 1 | — |
| Equity securities | 244 | 22 | — | — | — | 266 | 22 | — |
| Mortgage loans | 1,296 | 10 | — | (31) | — | 1,275 | 8 | — |
| Investment funds | 1,180 | 114 | — | 3 | — | 1,297 | 115 | — |
| Funds withheld at interest – embedded derivative | (540) | 62 | — | — | — | (478) | — | — |
| Other investments | 340 | (1) | — | — | — | 339 | (1) | — |
| Reinsurance recoverable | 1,729 | 5 | — | 46 | — | 1,780 | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 2,170 | 150 | — | 29 | (11) | 2,338 | 148 | — |
| Mortgage loans | 2,519 | 110 | — | (85) | — | 2,544 | 111 | — |
| Investment funds | 289 | (18) | — | (1) | — | 270 | (18) | — |
| Other investments | 91 | (4) | — | 279 | — | 366 | 5 | — |
| Total Level 3 assets | $110,203 | $1,381 | $422 | $9,847 | $(718) | $121,135 | $1,259 | $439 |
| Liabilities | ||||||||
| Interest sensitive contract liabilities | ||||||||
| Embedded derivative | $(10,747) | $(887) | $— | $(642) | $— | $(12,276) | $— | $— |
| Universal life benefits | (769) | 14 | — | — | — | (755) | — | — |
| Future policy benefits | ||||||||
| AmerUs Closed Block | (1,107) | 10 | — | — | — | (1,097) | — | — |
| ILICO Closed Block and life benefits | (556) | — | — | — | — | (556) | — | — |
| Other liabilities | (230) | (65) | — | — | — | (295) | — | — |
| Total Level 3 liabilities | $(13,409) | $(928) | $— | $(642) | $— | $(14,979) | $— | $— |
| 1 Related to instruments held at end of period. | ||||||||
| Three months ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total realized and unrealized gains (losses) | ||||||||
| (In millions) | Beginning balance | Included in income | Included in OCI | Net purchases, issuances, sales and settlements | Net transfers in (out) | Ending balance | Total gains (losses) included in earnings1 | Total gains (losses) included in OCI1 |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $40 | $— | $— | $(6) | $— | $34 | $— | $— |
| Corporate | 3,378 | (1) | 5 | 5,463 | (731) | 8,114 | (1) | 21 |
| ABS | 7,165 | (17) | (12) | 1,349 | (65) | 8,420 | — | (15) |
| CMBS | 21 | (1) | — | — | — | 20 | — | (1) |
| RMBS | 265 | 2 | 1 | (5) | (2) | 261 | — | (1) |
| Trading securities | 40 | — | — | (3) | — | 37 | — | — |
| Equity securities | 27 | — | — | — | 9 | 36 | — | — |
| Mortgage loans | 48,207 | 70 | — | 4,368 | — | 52,645 | 69 | — |
| Funds withheld at interest – embedded derivative | (3,362) | 79 | — | — | — | (3,283) | — | — |
| Derivative assets | 1 | — | — | — | — | 1 | — | — |
| Short-term investments | 101 | — | — | (20) | (1) | 80 | — | — |
| Other investments | 751 | (3) | — | 156 | — | 904 | (3) | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 1,175 | — | 22 | (3) | — | 1,194 | — | 22 |
| CLO | 520 | — | 1 | — | — | 521 | — | 1 |
| ABS | 10,043 | 17 | (39) | 559 | — | 10,580 | (1) | (40) |
| Trading securities | 781 | (1) | — | (61) | — | 719 | (1) | — |
| Equity securities | 249 | (2) | — | — | — | 247 | (2) | — |
| Mortgage loans | 1,263 | 19 | — | 38 | — | 1,320 | 19 | — |
| Investment funds | 1,067 | (1) | — | — | — | 1,066 | (1) | — |
| Funds withheld at interest – embedded derivative | (723) | 6 | — | — | — | (717) | — | — |
| Other investments | 336 | (1) | — | — | — | 335 | (1) | — |
| Reinsurance recoverable | 1,468 | (40) | — | 90 | — | 1,518 | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 1,770 | (18) | — | 124 | — | 1,876 | (18) | — |
| Mortgage loans | 2,147 | (7) | — | (20) | — | 2,120 | (7) | — |
| Investment funds | 951 | (38) | — | — | — | 913 | (38) | — |
| Other investments | 115 | (2) | — | — | — | 113 | (2) | — |
| Total Level 3 assets | $77,796 | $61 | $(22) | $12,029 | $(790) | $89,074 | $13 | $(13) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities | ||||||||
| Embedded derivative | $(10,908) | $182 | $— | $(508) | $— | $(11,234) | $— | $— |
| Universal life benefits | (788) | 19 | — | — | — | (769) | — | — |
| Future policy benefits | ||||||||
| AmerUs Closed Block | (1,151) | 31 | — | — | — | (1,120) | — | — |
| ILICO Closed Block and life benefits | (553) | 24 | — | — | — | (529) | — | — |
| Derivative liabilities | (1) | — | — | — | — | (1) | — | — |
| Other liabilities | (229) | (27) | — | 3 | — | (253) | — | — |
| Total Level 3 liabilities | $(13,630) | $229 | $— | $(505) | $— | $(13,906) | $— | $— |
| 1 Related to instruments held at end of period. | ||||||||
| Six months ended June 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total realized and unrealized gains (losses) | ||||||||
| (In millions) | Beginning balance | Included in income | Included in OCI | Net purchases, issuances, sales and settlements | Net transfers in (out) | Ending balance | Total gains (losses) included in earnings1 | Total gains (losses) included in OCI1 |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $29 | $(1) | $— | $(5) | $— | $23 | $— | $— |
| Corporate | 4,321 | 70 | 78 | 3,101 | (178) | 7,392 | 63 | 72 |
| ABS | 16,529 | 5 | 473 | 2,082 | (4,945) | 14,144 | 4 | 494 |
| CMBS | — | (23) | (4) | 28 | (1) | — | — | — |
| RMBS | 256 | 9 | 1 | 281 | (49) | 498 | — | 1 |
| Trading securities | 22 | — | — | 10 | (14) | 18 | (6) | — |
| Equity securities | 27 | (1) | — | (18) | — | 8 | (1) | — |
| Mortgage loans | 63,239 | 1,772 | — | 12,278 | — | 77,289 | 1,750 | — |
| Funds withheld at interest – embedded derivative | (3,035) | 292 | — | — | — | (2,743) | — | — |
| Derivative assets | 1 | — | — | — | — | 1 | — | — |
| Short-term investments | 169 | — | — | (156) | (1) | 12 | — | — |
| Other investments | 895 | 2 | — | (156) | — | 741 | (1) | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 1,432 | 7 | 30 | 7 | — | 1,476 | — | 29 |
| CLO | 696 | — | (2) | 376 | — | 1,070 | — | (2) |
| ABS | 9,741 | 3 | 50 | 1,031 | (15) | 10,810 | — | 41 |
| Trading securities | 573 | — | — | (174) | — | 399 | 1 | — |
| Equity securities | 234 | 32 | — | — | — | 266 | 32 | — |
| Mortgage loans | 1,297 | 24 | — | (46) | — | 1,275 | 25 | — |
| Investment funds | 1,139 | 155 | — | 3 | — | 1,297 | 155 | — |
| Funds withheld at interest – embedded derivative | (615) | 137 | — | — | — | (478) | — | — |
| Other investments | 331 | 8 | — | — | — | 339 | 8 | — |
| Reinsurance recoverable | 1,661 | 35 | — | 84 | — | 1,780 | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 1,954 | 217 | — | 190 | (23) | 2,338 | 214 | — |
| Mortgage loans | 2,579 | 137 | — | (172) | — | 2,544 | 141 | — |
| Investment funds | 770 | (3) | — | (497) | — | 270 | (15) | — |
| Other investments | 103 | — | — | 263 | — | 366 | 7 | — |
| Total Level 3 assets | $104,348 | $2,877 | $626 | $18,510 | $(5,226) | $121,135 | $2,377 | $635 |
| Liabilities | ||||||||
| Interest sensitive contract liabilities | ||||||||
| Embedded derivative | $(11,242) | $116 | $— | $(1,150) | $— | $(12,276) | $— | $— |
| Universal life benefits | (742) | (13) | — | — | — | (755) | — | — |
| Future policy benefits | ||||||||
| AmerUs Closed Block | (1,102) | 5 | — | — | — | (1,097) | — | — |
| ILICO Closed Block and life benefits | (538) | (18) | — | — | — | (556) | — | — |
| Derivative liabilities | (1) | 1 | — | — | — | — | — | — |
| Other liabilities | (225) | (71) | — | 1 | — | (295) | — | — |
| Total Level 3 liabilities | $(13,850) | $20 | $— | $(1,149) | $— | $(14,979) | $— | $— |
| 1 Related to instruments held at end of period. | ||||||||
| Six months ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total realized and unrealized gains (losses) | ||||||||
| (In millions) | Beginning balance | Included in income | Included in OCI | Net purchases, issuances, sales and settlements | Net transfers in (out) | Ending balance | Total gains (losses) included in earnings1 | Total gains (losses) included in OCI1 |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $40 | $— | $— | $(6) | $— | $34 | $— | $— |
| Corporate | 2,525 | (3) | 7 | 6,307 | (722) | 8,114 | (2) | 19 |
| ABS | 6,943 | (15) | 1 | 1,474 | 17 | 8,420 | — | — |
| CMBS | 21 | (1) | — | — | — | 20 | — | — |
| RMBS | 265 | 3 | 1 | (6) | (2) | 261 | — | (1) |
| Trading securities | 28 | — | — | (5) | 14 | 37 | (1) | — |
| Equity securities | 26 | — | — | 1 | 9 | 36 | — | — |
| Mortgage loans | 44,115 | (271) | — | 8,801 | — | 52,645 | (271) | — |
| Funds withheld at interest – embedded derivative | (3,379) | 96 | — | — | — | (3,283) | — | — |
| Derivative assets | — | — | — | — | 1 | 1 | — | — |
| Short-term investments | 105 | — | — | (24) | (1) | 80 | — | — |
| Other investments | 630 | (6) | — | 280 | — | 904 | (6) | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 1,171 | 1 | 21 | 1 | — | 1,194 | — | 21 |
| CLO | 506 | — | 15 | — | — | 521 | — | 15 |
| ABS | 7,826 | 18 | (53) | 2,789 | — | 10,580 | (6) | (55) |
| Trading securities | 838 | (1) | — | (118) | — | 719 | (1) | — |
| Equity securities | 255 | (8) | — | — | — | 247 | (7) | — |
| Mortgage loans | 1,281 | 2 | — | 37 | — | 1,320 | 2 | — |
| Investment funds | 1,082 | (16) | — | — | — | 1,066 | (16) | — |
| Funds withheld at interest – embedded derivative | (721) | 4 | — | — | — | (717) | — | — |
| Other investments | 343 | (8) | — | — | — | 335 | (8) | — |
| Reinsurance recoverable | 1,367 | (48) | — | 199 | — | 1,518 | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 1,852 | (51) | — | 69 | 6 | 1,876 | (52) | — |
| Mortgage loans | 2,173 | (49) | — | (4) | — | 2,120 | (49) | — |
| Investment funds | 977 | (65) | — | 1 | — | 913 | (64) | — |
| Other investments | 101 | (4) | — | 16 | — | 113 | (3) | — |
| Total Level 3 assets | $70,370 | $(422) | $(8) | $19,812 | $(678) | $89,074 | $(484) | $(1) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities | ||||||||
| Embedded derivative | $(9,059) | $(995) | $— | $(1,180) | $— | $(11,234) | $— | $— |
| Universal life benefits | (834) | 65 | — | — | — | (769) | — | — |
| Future policy benefits | ||||||||
| AmerUs Closed Block | (1,178) | 58 | — | — | — | (1,120) | — | — |
| ILICO Closed Block and life benefits | (522) | (7) | — | — | — | (529) | — | — |
| Derivative liabilities | (1) | — | — | — | — | (1) | — | — |
| Other liabilities | (330) | (37) | — | 50 | 64 | (253) | — | — |
| Total Level 3 liabilities | $(11,924) | $(916) | $— | $(1,130) | $64 | $(13,906) | $— | $— |
| 1 Related to instruments held at end of period. | ||||||||
The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above:
| Three months ended June 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Purchases | Issuances | Sales | Settlements | Net purchases, issuances, sales and settlements | Transfers in | Transfers out | Net transfers in (out) |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $— | $— | $— | $(5) | $(5) | $— | $— | $— |
| Corporate | 1,902 | — | — | (222) | 1,680 | — | — | — |
| ABS | 2,563 | — | (11) | (626) | 1,926 | — | (643) | (643) |
| RMBS | 248 | — | — | (14) | 234 | — | (49) | (49) |
| Trading securities | 11 | — | — | — | 11 | — | — | — |
| Equity securities | — | — | — | (18) | (18) | — | — | — |
| Mortgage loans | 8,750 | — | (40) | (3,109) | 5,601 | — | — | — |
| Short-term investments | — | — | — | (36) | (36) | — | — | — |
| Other investments | — | — | — | (156) | (156) | — | — | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 4 | — | — | (3) | 1 | — | — | — |
| ABS | 1,069 | — | — | (662) | 407 | — | (15) | (15) |
| Trading securities | 50 | — | — | (88) | (38) | — | — | — |
| Mortgage loans | — | — | — | (31) | (31) | — | — | — |
| Investment funds | 3 | — | — | — | 3 | — | — | — |
| Reinsurance recoverable | — | 49 | — | (3) | 46 | — | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 291 | — | (262) | — | 29 | — | (11) | (11) |
| Mortgage loans | 19 | — | (3) | (101) | (85) | — | — | — |
| Investment funds | — | — | (1) | — | (1) | — | — | — |
| Other investments | 279 | — | — | — | 279 | — | — | — |
| Total Level 3 assets | $15,189 | $49 | $(317) | $(5,074) | $9,847 | $— | $(718) | $(718) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities – embedded derivative | $— | $(861) | $— | $219 | $(642) | $— | $— | $— |
| Total Level 3 liabilities | $— | $(861) | $— | $219 | $(642) | $— | $— | $— |
| Three months ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Purchases | Issuances | Sales | Settlements | Net purchases, issuances, sales and settlements | Transfers in | Transfers out | Net transfers in (out) |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $— | $— | $— | $(6) | $(6) | $— | $— | $— |
| Corporate | 5,549 | — | (65) | (21) | 5,463 | 89 | (820) | (731) |
| ABS | 1,558 | — | (7) | (202) | 1,349 | 205 | (270) | (65) |
| RMBS | — | — | — | (5) | (5) | — | (2) | (2) |
| Trading securities | — | — | — | (3) | (3) | — | — | — |
| Equity securities | — | — | — | — | — | 9 | — | 9 |
| Mortgage loans | 6,022 | — | — | (1,654) | 4,368 | — | — | — |
| Short-term investments | 1 | — | — | (21) | (20) | — | (1) | (1) |
| Other investments | 156 | — | — | — | 156 | — | — | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | — | — | (1) | (2) | (3) | — | — | — |
| ABS | 1,894 | — | (304) | (1,031) | 559 | — | — | — |
| Trading securities | 2 | — | — | (63) | (61) | — | — | — |
| Mortgage loans | 87 | — | — | (49) | 38 | — | — | — |
| Reinsurance recoverable | — | 91 | — | (1) | 90 | — | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 163 | — | (32) | (7) | 124 | — | — | — |
| Mortgage loans | 23 | — | — | (43) | (20) | — | — | — |
| Total Level 3 assets | $15,455 | $91 | $(409) | $(3,108) | $12,029 | $303 | $(1,093) | $(790) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities – embedded derivative | $— | $(760) | $— | $252 | $(508) | $— | $— | $— |
| Other liabilities | — | — | — | 3 | 3 | — | — | — |
| Total Level 3 liabilities | $— | $(760) | $— | $255 | $(505) | $— | $— | $— |
| Six months ended June 30, 2025 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Purchases | Issuances | Sales | Settlements | Net purchases, issuances, sales and settlements | Transfers in | Transfers out | Net transfers in (out) |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $— | $— | $— | $(5) | $(5) | $— | $— | $— |
| Corporate | 3,457 | — | (6) | (350) | 3,101 | 96 | (274) | (178) |
| ABS | 3,029 | — | (23) | (924) | 2,082 | 242 | (5,187) | (4,945) |
| CMBS | 28 | — | — | — | 28 | 13 | (14) | (1) |
| RMBS | 297 | — | — | (16) | 281 | — | (49) | (49) |
| Trading securities | 11 | — | — | (1) | 10 | — | (14) | (14) |
| Equity securities | — | — | — | (18) | (18) | — | — | — |
| Mortgage loans | 17,760 | — | (172) | (5,310) | 12,278 | — | — | — |
| Short-term investments | 12 | — | — | (168) | (156) | — | (1) | (1) |
| Other investments | — | — | — | (156) | (156) | — | — | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 13 | — | — | (6) | 7 | — | — | — |
| CLO | 376 | — | — | — | 376 | — | — | — |
| ABS | 2,273 | — | — | (1,242) | 1,031 | — | (15) | (15) |
| Trading securities | 72 | — | (91) | (155) | (174) | — | — | — |
| Mortgage loans | — | — | (15) | (31) | (46) | — | — | — |
| Investment funds | 3 | — | — | — | 3 | — | — | — |
| Reinsurance recoverable | — | 90 | — | (6) | 84 | — | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 525 | — | (335) | — | 190 | — | (23) | (23) |
| Mortgage loans | 34 | — | (10) | (196) | (172) | — | — | — |
| Investment funds | — | — | (497) | — | (497) | — | — | — |
| Other investments | 279 | — | (16) | — | 263 | — | — | — |
| Total Level 3 assets | $28,169 | $90 | $(1,165) | $(8,584) | $18,510 | $351 | $(5,577) | $(5,226) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities – embedded derivative | $— | $(1,613) | $— | $463 | $(1,150) | $— | $— | $— |
| Other liabilities | — | — | — | 1 | 1 | — | — | — |
| Total Level 3 liabilities | $— | $(1,613) | $— | $464 | $(1,149) | $— | $— | $— |
| Six months ended June 30, 2024 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (In millions) | Purchases | Issuances | Sales | Settlements | Net purchases, issuances, sales and settlements | Transfers in | Transfers out | Net transfers in (out) |
| Assets | ||||||||
| AFS securities | ||||||||
| Foreign governments | $— | $— | $— | $(6) | $(6) | $— | $— | $— |
| Corporate | 6,471 | — | (67) | (97) | 6,307 | 98 | (820) | (722) |
| ABS | 1,871 | — | (7) | (390) | 1,474 | 546 | (529) | 17 |
| RMBS | — | — | — | (6) | (6) | — | (2) | (2) |
| Trading securities | — | — | — | (5) | (5) | 14 | — | 14 |
| Equity securities | 2 | — | (1) | — | 1 | 9 | — | 9 |
| Mortgage loans | 11,708 | — | (26) | (2,881) | 8,801 | — | — | — |
| Derivative assets | — | — | — | — | — | 1 | — | 1 |
| Short-term investments | 3 | — | (6) | (21) | (24) | — | (1) | (1) |
| Other investments | 280 | — | — | — | 280 | — | — | — |
| Investments in related parties | ||||||||
| AFS securities | ||||||||
| Corporate | 6 | — | (1) | (4) | 1 | — | — | — |
| ABS | 4,587 | — | (504) | (1,294) | 2,789 | — | — | — |
| Trading securities | 4 | — | — | (122) | (118) | — | — | — |
| Mortgage loans | 87 | — | — | (50) | 37 | — | — | — |
| Reinsurance recoverable | — | 200 | — | (1) | 199 | — | — | — |
| Assets of consolidated VIEs | ||||||||
| Trading securities | 163 | — | (87) | (7) | 69 | 6 | — | 6 |
| Mortgage loans | 55 | — | — | (59) | (4) | — | — | — |
| Investment funds | 1 | — | — | — | 1 | — | — | — |
| Other investments | 19 | — | (3) | — | 16 | — | — | — |
| Total Level 3 assets | $25,257 | $200 | $(702) | $(4,943) | $19,812 | $674 | $(1,352) | $(678) |
| Liabilities | ||||||||
| Interest sensitive contract liabilities – embedded derivative | $— | $(1,658) | $— | $478 | $(1,180) | $— | $— | $— |
| Other liabilities | — | — | — | 50 | 50 | 64 | — | 64 |
| Total Level 3 liabilities | $— | $(1,658) | $— | $528 | $(1,130) | $64 | $— | $64 |
Significant Unobservable Inputs—Significant unobservable inputs occur when we cannot obtain or corroborate the quantitative detail of the inputs. This applies to fixed maturity securities, equity securities, mortgage loans and certain investment funds, as well as embedded derivatives in liabilities. Additional significant unobservable inputs are described below.
AFS, trading and equity securities –We use discounted cash flow models to calculate the fair value for certain fixed maturity and equity securities. The discount rate is a significant unobservable input because the credit spread includes adjustments made to the base rate. The base rate represents a market comparable rate for securities with similar characteristics. This excludes assets for which fair value is provided by independent broker quotes, but includes assets for which fair value is provided by affiliated quotes.
Mortgage loans –We use discounted cash flow models from independent commercial pricing services to calculate the fair value of our mortgage loan portfolio. The discount rate is a significant unobservable input. This approach uses market transaction information and client portfolio-oriented information, such as prepayments or defaults, to support the valuations.
Investment funds – We use various methods of valuing our investment funds from both independent pricing services and affiliated modeling.
Interest sensitive contract liabilities – embedded derivative – Significant unobservable inputs we use in the fixed indexed annuities embedded derivative of the interest sensitive contract liabilities valuation include:
Nonperformance risk – For contracts we issue, we use the credit spread, relative to the US Department of the Treasury (US Treasury) curve based on our public credit rating as of the valuation date. This represents our credit risk used in the fair value estimate of embedded derivatives.
Option budget – We assume future hedge costs in the derivative’s fair value estimate. The level of option budgets determines the future costs of the options and impacts future policyholder account value growth.
Policyholder behavior – We regularly review the full withdrawal (surrender rate) assumptions. These are based on our initial pricing assumptions updated for actual experience. Actual experience may be limited for recently issued products.
The following summarizes our significant unobservable inputs:
| (In millions, except percentages) · Fair value · Valuation technique · Unobservable inputs · Minimum · Maximum · Weighted average · Impact of an increase in the input on fair value | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFS, trading and equity securities | $29,142 | Discounted cash flow | Discount rate | 2.5% | 22.4% | 6.7% | 1 | Decrease | ||||||
| Mortgage loans | 81,108 | Discounted cash flow | Discount rate | 0.1% | 49.6% | 6.4% | 1 | Decrease | ||||||
| Investment funds | 1,294 | Discounted cash flow | Discount rate | 13.0% | 14.0% | 13.1% | 1 | Decrease | ||||||
| 281 | Recoverability | Estimated proceeds | N/A | N/A | N/A | N/A | ||||||||
| Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives | 12,276 | Discounted cash flow | Nonperformance risk | 0.3% | 1.1% | 0.7% | 2 | Decrease | ||||||
| Option budget | 0.5% | 6.0% | 3.0% | 3 | Increase | |||||||||
| Surrender rate | 5.7% | 13.5% | 8.8% | 3 | Decrease | |||||||||
| (In millions, except percentages) | Fair value | Valuation technique | Unobservable inputs | Minimum | Maximum | Weighted average | Impact of an increase in the input on fair value | |||||||
| AFS, trading and equity securities | $28,774 | Discounted cash flow | Discount rate | 4.7% | 20.0% | 7.1% | 1 | Decrease | ||||||
| Mortgage loans | 67,115 | Discounted cash flow | Discount rate | 1.8% | 43.1% | 6.7% | 1 | Decrease | ||||||
| Investment funds | 1,909 | Discounted cash flow | Discount rate | 6.6% | 14.0% | 10.8% | 1 | Decrease | ||||||
| Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives | 11,242 | Discounted cash flow | Nonperformance risk | 0.4% | 1.1% | 0.7% | 2 | Decrease | ||||||
| Option budget | 0.5% | 6.0% | 2.8% | 3 | Increase | |||||||||
| Surrender rate | 6.0% | 14.2% | 9.0% | 3 | Decrease | |||||||||
| 1 The discount rate weighted average is calculated based on the relative fair values of the investments. | ||||||||||||||
| 2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative. | ||||||||||||||
| 3 The option budget and surrender rate weighted averages are calculated based on projected account values. | ||||||||||||||
Fair Value of Financial Instruments Not Carried at Fair Value—The following represents our financial instruments not carried at fair value on the condensed consolidated balance sheets:
| June 30, 2025 | ||||||
|---|---|---|---|---|---|---|
| (In millions) | Carrying Value | Fair Value | NAV | Level 1 | Level 2 | Level 3 |
| Financial assets | ||||||
| Investment funds | $102 | $102 | $102 | $— | $— | $— |
| Policy loans | 310 | 310 | — | — | 310 | — |
| Funds withheld at interest | 19,741 | 19,741 | — | — | — | 19,741 |
| Short-term investments | 171 | 171 | — | — | — | 171 |
| Other investments | 225 | 58 | — | — | — | 58 |
| Investments in related parties | ||||||
| Investment funds | 765 | 765 | 765 | — | — | — |
| Funds withheld at interest | 5,068 | 5,068 | — | — | — | 5,068 |
| Short-term investments | 18 | 18 | — | — | 18 | — |
| Total financial assets not carried at fair value | $26,400 | $26,233 | $867 | $— | $328 | $25,038 |
| Financial liabilities | ||||||
| Interest sensitive contract liabilities | $236,927 | $232,387 | $— | $— | $— | $232,387 |
| Debt | 7,864 | 7,507 | — | 577 | 6,930 | — |
| Securities to repurchase | 3,537 | 3,537 | — | — | 3,537 | — |
| Funds withheld liability | 4,503 | 4,503 | — | — | — | 4,503 |
| Total financial liabilities not carried at fair value | $252,831 | $247,934 | $— | $577 | $10,467 | $236,890 |
| December 31, 2024 | ||||||
|---|---|---|---|---|---|---|
| (In millions) | Carrying Value | Fair Value | NAV | Level 1 | Level 2 | Level 3 |
| Financial assets | ||||||
| Investment funds | $107 | $107 | $107 | $— | $— | $— |
| Policy loans | 318 | 318 | — | — | 318 | — |
| Funds withheld at interest | 21,901 | 21,901 | — | — | — | 21,901 |
| Short-term investments | 192 | 192 | — | — | — | 192 |
| Other investments | 93 | 101 | — | — | — | 101 |
| Investments in related parties | ||||||
| Investment funds | 714 | 714 | 714 | — | — | — |
| Funds withheld at interest | 5,665 | 5,665 | — | — | — | 5,665 |
| Short-term investments | 743 | 743 | — | — | 743 | — |
| Total financial assets not carried at fair value | $29,733 | $29,741 | $821 | $— | $1,061 | $27,859 |
| Financial liabilities | ||||||
| Interest sensitive contract liabilities | $200,278 | $192,025 | $— | $— | $— | $192,025 |
| Debt | 6,309 | 5,844 | — | 581 | 5,263 | — |
| Securities to repurchase | 5,716 | 5,716 | — | — | 5,716 | — |
| Funds withheld liability | 4,331 | 4,331 | — | — | — | 4,331 |
| Total financial liabilities not carried at fair value | $216,634 | $207,916 | $— | $581 | $10,979 | $196,356 |
We estimate the fair value for financial instruments not carried at fair value using the same methods and assumptions as those we carry at fair value. The financial instruments presented above are reported at carrying value on the condensed consolidated balance sheets; however, in the case of policy loans, funds withheld at interest and liability, short-term investments and securities to repurchase, the carrying amount approximates fair value.
Other investments –Other investments include investments in low-income housing and transferable energy tax credit structures. For those held using the proportional amortization method, the carrying value may include tax credits which have been received but not yet used, which are excluded from the measurement of the fair value estimate of the investment structures. Tax and other future benefits expected to be generated by these structures are valued using a discounted cash flow model. Received but unused tax credits included in the carrying value as of June 30, 2025 are expected to be used during the year ending December 31, 2025.
Interest sensitive contract liabilities –The carrying and fair value of interest sensitive contract liabilities above includes fixed indexed and traditional fixed annuities without mortality or morbidity risks, funding agreements, guaranteed investment contracts and payout annuities without life contingencies. The embedded derivatives within fixed indexed annuities without mortality or morbidity risks are excluded, as they are carried at fair value. The valuation of these investment contracts is based on discounted cash flow methodologies using significant unobservable inputs. The estimated fair value is determined using current market risk-free interest rates, adding a spread to reflect our nonperformance risk and subtracting a risk margin to reflect uncertainty inherent in the projected cash flows.
Debt– We obtain the fair value of debt from commercial pricing services. These are classified as Level 1 or Level 2. The pricing services use quoted market prices, if available, or incorporate a variety of market observable information in their valuation techniques including benchmark yields, trading activity, credit quality, issuer spreads, bids, offers and other reference data.
- Deferred Acquisition Costs, Deferred Sales Inducements and Value of Business Acquired
The following represents a rollforward of DAC and DSI by product, and a rollforward of VOBA. See Note 7 – Long-duration Contracts for more information on our products.
| Six months ended June 30, 2025 | |||||||
|---|---|---|---|---|---|---|---|
| DAC · DSI · VOBA · Total DAC, DSI and VOBA | |||||||
| (In millions) · Traditional deferred annuities · Indexed annuities · Funding agreements · Other investment-type and other · Indexed annuities | |||||||
| Balance at December 31, 2024 | $1,158 | $2,278 | $40 | $11 | $1,476 | $2,210 | $7,173 |
| Additions | 366 | 560 | 26 | 5 | 408 | — | 1,365 |
| Amortization | (169) | (122) | (11) | (1) | (84) | (172) | (559) |
| Other | 2 | — | — | — | — | — | 2 |
| Balance at June 30, 2025 | $1,357 | $2,716 | $55 | $15 | $1,800 | $2,038 | $7,981 |
| Six months ended June 30, 2024 | |||||||
|---|---|---|---|---|---|---|---|
| DAC · DSI · VOBA · Total DAC, DSI and VOBA | |||||||
| (In millions) · Traditional deferred annuities · Indexed annuities · Funding agreements · Other investment-type and other · Indexed annuities | |||||||
| Balance at December 31, 2023 | $890 | $1,517 | $10 | $11 | $970 | $2,581 | $5,979 |
| Additions | 279 | 525 | 24 | — | 328 | — | 1,156 |
| Amortization | (109) | (82) | (5) | (1) | (55) | (182) | (434) |
| Other | (2) | — | — | — | — | — | (2) |
| Balance at June 30, 2024 | $1,058 | $1,960 | $29 | $10 | $1,243 | $2,399 | $6,699 |
Deferred costs related to universal life-type policies and investment contracts with significant revenue streams from sources other than investment of the policyholder funds, including traditional deferred annuities and indexed annuities, are amortized on a constant-level basis for a cohort of contracts using initial premium or deposit. Significant inputs and assumptions are required for determining the expected duration of the cohort and involves using accepted actuarial methods to determine decrement rates related to policyholder behavior for lapses, withdrawals (surrenders) and mortality. The assumptions used to determine the amortization of DAC and DSI are consistent with those used to estimate the related liability balance.
Deferred costs related to investment contracts without significant revenue streams from sources other than investment of policyholder funds are amortized using the effective interest method, which primarily includes funding agreements. The effective interest method requires inputs to project future cash flows, which for funding agreements includes contractual terms of notional value, periodic interest payments based on either fixed or floating interest rates, and duration. For other investment-type contracts which include immediate annuities and assumed endowments without significant mortality risks, assumptions are required related to policyholder behavior for lapses and withdrawals (surrenders).
- Long-duration Contracts
Interest sensitive contract liabilities –Interest sensitive contract liabilities primarily include:
traditional deferred annuities;
indexed annuities consisting of fixed indexed, index-linked variable annuities, and assumed indexed universal life without significant mortality risk;
funding agreements; and
other investment-type contracts comprising of immediate annuities without significant mortality risk (which includes pension group annuities without life contingencies), guaranteed investment contracts, and assumed endowments without significant mortality risks.
The following represents a rollforward of the policyholder account balance by product within interest sensitive contract liabilities. Where explicit policyholder account balances do not exist, the disaggregated rollforward represents the recorded reserve.
| Six months ended June 30, 2025 | |||||
|---|---|---|---|---|---|
| (In millions, except percentages) | Traditional deferred annuities | Indexed annuities | Funding agreements | Other investment-type | Total |
| Balance at December 31, 2024 | $86,661 | $97,861 | $54,768 | $8,030 | $247,320 |
| Deposits | 15,357 | 8,868 | 21,676 | 502 | 46,403 |
| Policy charges | (1) | (382) | — | — | (383) |
| Surrenders and withdrawals | (2,913) | (5,601) | — | (36) | (8,550) |
| Benefit payments | (703) | (807) | (3,906) | (153) | (5,569) |
| Interest credited | 2,098 | 1,376 | 1,456 | 110 | 5,040 |
| Foreign exchange | 337 | 7 | 1,021 | 437 | 1,802 |
| Other | — | — | 213 | (34) | 179 |
| Balance at June 30, 2025 | $100,836 | $101,322 | $75,228 | $8,856 | $286,242 |
| Weighted average crediting rate | 4.6% | 2.7% | 4.6% | 2.7% | |
| Net amount at risk | $420 | $15,997 | $— | $39 | |
| Cash surrender value | 94,874 | 93,191 | — | 7,191 | |
| Six months ended June 30, 2024 | |||||
|---|---|---|---|---|---|
| (In millions, except percentages) | Traditional deferred annuities | Indexed annuities | Funding agreements | Other investment-type | Total |
| Balance at December 31, 2023 | $64,763 | $93,147 | $32,350 | $7,629 | $197,889 |
| Deposits | 13,436 | 8,823 | 14,511 | 708 | 37,478 |
| Policy charges | (1) | (342) | — | — | (343) |
| Surrenders and withdrawals | (2,511) | (6,350) | — | (44) | (8,905) |
| Benefit payments | (557) | (845) | (6,032) | (113) | (7,547) |
| Interest credited | 1,466 | 1,400 | 703 | 100 | 3,669 |
| Foreign exchange | (357) | (4) | (180) | (583) | (1,124) |
| Other | — | — | (64) | (50) | (114) |
| Balance at June 30, 2024 | $76,239 | $95,829 | $41,288 | $7,647 | $221,003 |
| Weighted average crediting rate | 4.2% | 2.5% | 4.3% | 2.7% | |
| Net amount at risk | $427 | $15,185 | $— | $71 | |
| Cash surrender value | 71,380 | 87,449 | — | 6,404 | |
The following is a reconciliation of interest sensitive contract liabilities to the condensed consolidated balance sheets:
| June 30, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Traditional deferred annuities | $100,836 | $76,239 |
| Indexed annuities | 101,322 | 95,829 |
| Funding agreements | 75,228 | 41,288 |
| Other investment-type | 8,856 | 7,647 |
| Reconciling items1 | 5,996 | 7,386 |
| Interest sensitive contract liabilities | $292,238 | $228,389 |
| 1 Reconciling items primarily include embedded derivatives in indexed annuities, unaccreted host contract adjustments on indexed annuities, negative VOBA, sales inducement liabilities, and wholly ceded universal life insurance contracts. | ||
The following represents policyholder account balances by range of guaranteed minimum crediting rates (GMCR), as well as the related range of the difference between rates being credited to policyholders and the respective guaranteed minimums. Our funding agreements and other investment-type products provide us little to no discretionary ability to change the rates of interest payable to the respective policyholder or institution, and as a result, those policyholder account balances are excluded from the following tables.
| June 30, 2025 | ||||
|---|---|---|---|---|
| (In millions) | At guaranteed minimum | 1 basis point – 100 basis points above guaranteed minimum | Greater than 100 basis points above guaranteed minimum | Total |
| Traditional deferred annuities | ||||
| < 2.0% | $5,071 | $1,857 | $80,432 | $87,360 |
| 2.0% – < 4.0% | 5,962 | 610 | 2,598 | 9,170 |
| 4.0% – < 6.0% | 4,300 | 2 | 1 | 4,303 |
| 6.0% and greater | 3 | — | — | 3 |
| Total traditional deferred annuities | $15,336 | $2,469 | $83,031 | $100,836 |
| Indexed annuities | ||||
| < 2.0% | $1,544 | $1,182 | $3,280 | $6,006 |
| 2.0% – < 4.0% | 4,070 | 37 | — | 4,107 |
| Total indexed annuities with GMCR | 5,614 | 1,219 | 3,280 | 10,113 |
| Other1 | 91,209 | |||
| Total indexed annuities | $101,322 | |||
| 1 Includes account value allocated to an indexed strategy or other amounts without a GMCR. | ||||
| June 30, 2024 | ||||
|---|---|---|---|---|
| (In millions) | At guaranteed minimum | 1 basis point – 100 basis points above guaranteed minimum | Greater than 100 basis points above guaranteed minimum | Total |
| Traditional deferred annuities | ||||
| < 2.0% | $4,003 | $3,029 | $56,813 | $63,845 |
| 2.0% – < 4.0% | 7,127 | 434 | 1,466 | 9,027 |
| 4.0% – < 6.0% | 3,354 | 9 | 1 | 3,364 |
| 6.0% and greater | 3 | — | — | 3 |
| Total traditional deferred annuities | $14,487 | $3,472 | $58,280 | $76,239 |
| Indexed annuities | ||||
| < 2.0% | $2,069 | $1,492 | $2,962 | $6,523 |
| 2.0% – < 4.0% | 4,826 | 53 | 17 | 4,896 |
| Total indexed annuities with GMCR | 6,895 | 1,545 | 2,979 | 11,419 |
| Other1 | 84,410 | |||
| Total indexed annuities | $95,829 | |||
| 1 Includes account value allocated to an indexed strategy or other amounts without a GMCR. | ||||
| Note: The amounts presented in this table have been revised to conform with the current year presentation to provide certain product-level detail and account value allocated to an indexed strategy or other amounts without a GMCR. | ||||
Future policy benefits –Future policy benefits consist primarily of payout annuities, including single premium immediate annuities with life contingencies (which include pension group annuities with life contingencies), and whole life insurance contracts.
The following is a rollforward by product within future policy benefits:
| Six months ended June 30, 2025 | ||||
|---|---|---|---|---|
| (In millions, except percentages and years) · Payout annuities with life contingencies · Whole life · Total | ||||
| Present value of expected net premiums | ||||
| Beginning balance | $— | $880 | $880 | |
| Effect of changes in discount rate assumptions | — | (30) | (30) | |
| Effect of foreign exchange on the change in discount rate assumptions | — | 2 | 2 | |
| Beginning balance at original discount rate | — | 852 | 852 | |
| Effect of actual to expected experience | — | (1) | (1) | |
| Adjusted balance | — | 851 | 851 | |
| Interest accrual | — | 10 | 10 | |
| Net premium collected | — | (92) | (92) | |
| Foreign exchange | — | 76 | 76 | |
| Ending balance at original discount rate | — | 845 | 845 | |
| Effect of changes in discount rate assumptions | — | 23 | 23 | |
| Ending balance, present value of expected net premiums | $— | $868 | $868 | |
| Present value of expected future policy benefits | ||||
| Beginning balance | $42,261 | $2,711 | $44,972 | |
| Effect of changes in discount rate assumptions | 7,378 | 206 | 7,584 | |
| Effect of foreign exchange on the change in discount rate assumptions | (5) | (1) | (6) | |
| Beginning balance at original discount rate | 49,634 | 2,916 | 52,550 | |
| Effect of actual to expected experience | (64) | 2 | (62) | |
| Adjusted balance | 49,570 | 2,918 | 52,488 | |
| Issuances | 133 | — | 133 | |
| Interest accrual | 879 | 35 | 914 | |
| Benefit payments | (2,238) | (49) | (2,287) | |
| Foreign exchange | 75 | 270 | 345 | |
| Ending balance at original discount rate | 48,419 | 3,174 | 51,593 | |
| Effect of changes in discount rate assumptions | (6,465) | (553) | (7,018) | |
| Effect of foreign exchange on the change in discount rate assumptions | (28) | (24) | (52) | |
| Ending balance, present value of expected future policy benefits | 41,926 | 2,597 | 44,523 | |
| Less: Present value of expected net premiums | — | 868 | 868 | |
| Net future policy benefits | $41,926 | $1,729 | $43,655 | |
| Weighted-average liability duration (in years) | 9.4 | 29.4 | ||
| Weighted-average interest accretion rate | 3.7% | 4.8% | ||
| Weighted-average current discount rate | 5.3% | 5.1% | ||
| Expected future gross premiums, undiscounted | $— | $1,064 | ||
| Expected future gross premiums, discounted1 | — | 919 | ||
| Expected future benefit payments, undiscounted | 70,754 | 10,085 | ||
| 1 Discounted at the original discount rate. | ||||
| Six months ended June 30, 2024 | ||||
|---|---|---|---|---|
| (In millions, except percentages and years) · Payout annuities with life contingencies · Whole life · Total | ||||
| Present value of expected net premiums | ||||
| Beginning balance | $— | $1,182 | $1,182 | |
| Effect of changes in discount rate assumptions | — | (45) | (45) | |
| Effect of foreign exchange on the change in discount rate assumptions | — | (2) | (2) | |
| Beginning balance at original discount rate | — | 1,135 | 1,135 | |
| Effect of actual to expected experience | — | (6) | (6) | |
| Adjusted balance | — | 1,129 | 1,129 | |
| Interest accrual | — | 11 | 11 | |
| Net premium collected | — | (98) | (98) | |
| Foreign exchange | — | (135) | (135) | |
| Ending balance at original discount rate | — | 907 | 907 | |
| Effect of changes in discount rate assumptions | — | 38 | 38 | |
| Effect of foreign exchange on the change in discount rate assumptions | — | (3) | (3) | |
| Ending balance, present value of expected net premiums | $— | $942 | $942 | |
| Present value of expected future policy benefits | ||||
| Beginning balance | $45,001 | $3,371 | $48,372 | |
| Effect of changes in discount rate assumptions | 6,233 | (89) | 6,144 | |
| Effect of foreign exchange on the change in discount rate assumptions | 1 | (6) | (5) | |
| Beginning balance at original discount rate | 51,235 | 3,276 | 54,511 | |
| Effect of actual to expected experience | (29) | (9) | (38) | |
| Adjusted balance | 51,206 | 3,267 | 54,473 | |
| Issuances | 670 | — | 670 | |
| Interest accrual | 901 | 35 | 936 | |
| Benefit payments | (2,243) | (44) | (2,287) | |
| Foreign exchange | (6) | (404) | (410) | |
| Ending balance at original discount rate | 50,528 | 2,854 | 53,382 | |
| Effect of changes in discount rate assumptions | (7,537) | (45) | (7,582) | |
| Effect of foreign exchange on the change in discount rate assumptions | 1 | (1) | — | |
| Ending balance, present value of expected future policy benefits | 42,992 | 2,808 | 45,800 | |
| Less: Present value of expected net premiums | — | 942 | 942 | |
| Net future policy benefits | $42,992 | $1,866 | $44,858 | |
| Weighted-average liability duration (in years) | 9.4 | 32.2 | ||
| Weighted-average interest accretion rate | 3.7% | 4.8% | ||
| Weighted-average current discount rate | 5.6% | 4.4% | ||
| Expected future gross premiums, undiscounted | $— | $1,201 | ||
| Expected future gross premiums, discounted1 | — | 992 | ||
| Expected future benefit payments, undiscounted | 74,184 | 10,247 | ||
| 1 Discounted at the original discount rate. | ||||
The following is a reconciliation of future policy benefits to the condensed consolidated balance sheets:
| June 30, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Payout annuities with life contingencies | $41,926 | $42,992 |
| Whole life | 1,729 | 1,866 |
| Reconciling items1 | 5,745 | 5,941 |
| Future policy benefits | $49,400 | $50,799 |
| 1 Reconciling items primarily include the deferred profit liability and negative VOBA associated with the liability for future policy benefits. Additionally, it includes term life reserves, fully ceded whole life reserves, and reserves for immaterial lines of business including accident and health and disability, as well as other insurance benefit reserves for no-lapse guarantees with universal life contracts, all of which are fully ceded. | ||
The following is a reconciliation of premiums and interest expense relating to future policy benefits to the condensed consolidated statements of income:
| Premiums · Interest expense | ||||
|---|---|---|---|---|
| Six months ended June 30, | Six months ended June 30, | |||
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Payout annuities with life contingencies | $122 | $655 | $879 | $901 |
| Whole life | 101 | 105 | 25 | 23 |
| Reconciling items1 | 11 | 14 | — | — |
| Total | $234 | $774 | $904 | $924 |
| 1 Reconciling items primarily relate to immaterial lines of business including term life, fully ceded whole life, and accident and health and disability. | ||||
Significant assumptions and inputs to the calculation of future policy benefits for payout annuities with life contingencies include policyholder demographic data, assumptions for policyholder longevity and policyholder utilization for contracts with deferred lives, and discount rates. For whole life products, significant assumptions and inputs include policyholder demographic data, assumptions for mortality, morbidity, and lapse and discount rates.
We base certain key assumptions related to policyholder behavior on industry standard data adjusted to align with actual company experience, if necessary. At least annually, we review all significant cash flow assumptions and update as necessary, unless emerging experience indicates a more frequent review is necessary. The discount rate reflects market observable inputs from upper-medium grade fixed income instrument yields and is interpolated, where necessary, to conform to the duration of our liabilities.
During the six months ended June 30, 2025, the present value of expected future policy benefits decreased by $449 million, which was driven by $2,287 million of benefit payments, offset by $914 million of interest accruals, a $573 million change in discount rate assumptions related to a decrease in market observable rates, a $345 million change in foreign exchange and $133 million of issuances, primarily pension group annuities.
During the six months ended June 30, 2024, the present value of expected future policy benefits decreased by $2,572 million, which was driven by $2,287 million of benefit payments and a $1,431 million change in discount rate assumptions related to an increase in market observable rates, partially offset by $936 million of interest accrual.
The following is a summary of remeasurement gains (losses) included within future policy and other policy benefits on the condensed consolidated statements of income:
| Six months ended June 30, | ||
|---|---|---|
| (In millions) | 2025 | 2024 |
| Reserves | $61 | $32 |
| Deferred profit liability | 2 | (29) |
| Negative VOBA | (3) | (10) |
| Total remeasurement gains (losses) | $60 | $(7) |
During the six months ended June 30, 2025 and 2024, we recorded reserve increases of $8 million and $35 million, respectively, on the condensed consolidated statements of income as a result of the present value of benefits and expenses exceeding the present value of gross premiums.
Market risk benefits –We issue and reinsure traditional deferred and indexed annuity products that contain guaranteed lifetime withdrawal benefit (GLWB) and guaranteed minimum death benefit (GMDB) riders that meet the criteria to be classified as market risk benefits.
The following is a rollforward of net market risk benefit liabilities by product:
| Six months ended June 30, 2025 | ||||
|---|---|---|---|---|
| (In millions, except years) · Traditional deferred annuities · Indexed annuities · Total | ||||
| Balance at December 31, 2024 | $190 | $3,525 | $3,715 | |
| Effect of changes in instrument-specific credit risk | (3) | (154) | (157) | |
| Balance, beginning of period, before changes in instrument-specific credit risk | 187 | 3,371 | 3,558 | |
| Issuances | — | 201 | 201 | |
| Interest accrual | 4 | 89 | 93 | |
| Attributed fees collected | 1 | 189 | 190 | |
| Benefit payments | (3) | (30) | (33) | |
| Effect of changes in interest rates | 3 | (29) | (26) | |
| Effect of actual policyholder behavior compared to expected behavior | — | 53 | 53 | |
| Balance, end of period, before changes in instrument-specific credit risk | 192 | 3,844 | 4,036 | |
| Effect of changes in instrument-specific credit risk | 3 | 173 | 176 | |
| Balance at June 30, 2025 | 195 | 4,017 | 4,212 | |
| Less: Reinsurance recoverable | — | 50 | 50 | |
| Balance at June 30, 2025, net of reinsurance | $195 | $3,967 | $4,162 | |
| Net amount at risk | $420 | $15,997 | ||
| Weighted-average attained age of contract holders (in years) | 76 | 69 | ||
| Six months ended June 30, 2024 | ||||
|---|---|---|---|---|
| (In millions, except years) · Traditional deferred annuities · Indexed annuities · Total | ||||
| Balance at December 31, 2023 | $192 | $3,181 | $3,373 | |
| Effect of changes in instrument-specific credit risk | 2 | (10) | (8) | |
| Balance, beginning of period, before changes in instrument specific credit risk | 194 | 3,171 | 3,365 | |
| Issuances | — | 159 | 159 | |
| Interest accrual | 5 | 94 | 99 | |
| Attributed fees collected | 1 | 174 | 175 | |
| Benefit payments | (2) | (27) | (29) | |
| Effect of changes in interest rates | (11) | (372) | (383) | |
| Effect of changes in equity | — | (81) | (81) | |
| Effect of actual policyholder behavior compared to expected behavior | 4 | 45 | 49 | |
| Balance, end of period, before changes in instrument-specific credit risk | 191 | 3,163 | 3,354 | |
| Effect of changes in instrument-specific credit risk | (2) | 4 | 2 | |
| Balance at June 30, 2024 | 189 | 3,167 | 3,356 | |
| Less: Reinsurance recoverable | — | 18 | 18 | |
| Balance at June 30, 2024, net of reinsurance | $189 | $3,149 | $3,338 | |
| Net amount at risk | $427 | $15,185 | ||
| Weighted-average attained age of contract holders (in years) | 76 | 69 | ||
The following is a reconciliation of market risk benefits to the condensed consolidated balance sheets. Market risk benefit assets are included in other assets on the condensed consolidated balance sheets.
| June 30, 2025 | June 30, 2024 | |||||
|---|---|---|---|---|---|---|
| (In millions) | Asset | Liability | Net liability | Asset | Liability | Net liability |
| Traditional deferred annuities | $— | $195 | $195 | $— | $189 | $189 |
| Indexed annuities | 277 | 4,294 | 4,017 | 371 | 3,538 | 3,167 |
| Total | $277 | $4,489 | $4,212 | $371 | $3,727 | $3,356 |
During the six months ended June 30, 2025, net market risk benefit liabilities increased by $497 million, which was primarily driven by $201 million of issuances, $190 million in fees collected from policyholders and $93 million of interest accruals.
During the six months ended June 30, 2024, net market risk benefit liabilities decreased by $17 million, which was primarily driven by a decrease of $383 million related to changes in the risk-free discount rate across the curve, offset by $175 million in fees collected from policyholders and $159 million of issuances.
The determination of the fair value of market risk benefits requires the use of inputs related to fees and assessments and assumptions in determining the projected benefits in excess of the projected account balance. Judgment is required for both economic and actuarial assumptions, which can be either observable or unobservable, that impact future policyholder account growth.
Economic assumptions include interest rates and implied volatilities throughout the duration of the liability. For indexed annuities, assumptions also include projected equity returns which impact cash flows attributable to indexed strategies, implied equity volatilities, expected index credits on the next policy anniversary date and future equity option costs. Assumptions related to the level of option budgets used for determining the future equity option costs and the impact on future policyholder account value growth are considered unobservable inputs.
Policyholder behavior assumptions are unobservable inputs and are established using accepted actuarial valuation methods to estimate withdrawals (surrender rate) and income rider utilization. Assumptions are generally based on industry data and pricing assumptions which are updated for actual experience, if necessary. Actual experience may be limited for recently issued products.
All inputs are used to project excess benefits and fees over a range of risk-neutral, stochastic interest rate scenarios. For indexed annuities, stochastic equity return scenarios are also included within the range. A risk margin is incorporated within the discount rate to reflect uncertainty in the projected cash flows such as variations in policyholder behavior, as well as a credit spread to reflect nonperformance risk, which is considered an unobservable input. We use our public credit rating relative to the US Treasury curve as of the valuation date to reflect our nonperformance risk in the fair value estimate of market risk benefits.
The following summarizes the unobservable inputs for market risk benefits:
| (In millions, except percentages) · Fair value · Valuation technique · Unobservable inputs · Minimum · Maximum · Weighted average · Impact of an increase in the input on fair value | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market risk benefits, net | $4,212 | Discounted cash flow | Nonperformance risk | 0.3% | 1.1% | 1.0% | 1 | Decrease | |||
| Option budget | 0.5% | 6.0% | 2.5% | 2 | Decrease | ||||||
| Surrender rate | 3.1% | 6.7% | 4.4% | 2 | Decrease | ||||||
| Utilization rate | 28.6% | 95.0% | 85.4% | 3 | Increase | ||||||
| (In millions, except percentages) | Fair value | Valuation technique | Unobservable inputs | Minimum | Maximum | Weighted average | Impact of an increase in the input on fair value | ||||
| Market risk benefits, net | $3,356 | Discounted cash flow | Nonperformance risk | 0.4% | 1.3% | 1.2% | 1 | Decrease | |||
| Option budget | 0.5% | 6.0% | 2.1% | 2 | Decrease | ||||||
| Surrender rate | 3.1% | 6.9% | 4.4% | 2 | Decrease | ||||||
| Utilization rate | 28.6% | 95.0% | 84.4% | 3 | Increase | ||||||
| 1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve. | |||||||||||
| 2 The option budget and surrender rate weighted averages are calculated based on projected account values. | |||||||||||
| 3 The utilization of GLWB withdrawals represents the estimated percentage of policyholders that are expected to use their income rider over the duration of the contract, with the weighted average based on current account values. | |||||||||||
- Debt
Liquidity Facility—On June 27, 2025, AHL, AARe, ALRe and AAIA entered into a revolving credit agreement with a syndicate of banks and Wells Fargo Bank, National Association, as administrative agent (Liquidity Facility), which replaced our previous revolving credit agreement dated as of June 28, 2024. The previous credit agreement, and the commitments under it, expired on June 27, 2025. The Liquidity Facility is unsecured and has a commitment termination date of June 26, 2026, subject to any extensions of additional 364-day periods with consent of extending lenders and/or “term-out” of outstanding loans (by which, at our election, the outstanding loans may be converted to term loans which shall have a maturity of up toone year after the original maturity date), in each case in accordance with the terms of the Liquidity Facility. In connection with the Liquidity Facility, AARe guaranteed all of the obligations of each other borrower under the Liquidity Facility and the related loan documents. The Liquidity Facility will be used for liquidity and working capital needs to meet short-term cash flow and investment timing differences. The borrowing capacity under the Liquidity Facility is $2.6 billion, subject to being increased up to $3.1 billion in total on the terms described in the Liquidity Facility. The Liquidity Facility contains various standard covenants with which we must comply, including the following:
AARe minimum consolidated net worth of no less than $23.2 billion; and
Restrictions on our ability to incur liens, with certain exceptions.
Interest accrues on outstanding borrowings at either the adjusted term secured overnight financing rate plus a margin or the base rate plus a margin, with applicable margin varying based on AARe’s financial strength rating. Rates and terms are as defined in the Liquidity Facility.
As of June 30, 2025 and December 31, 2024, we hadno amounts outstanding under the current or previous liquidity facilities and were in compliance with all financial covenants under the facilities.
Senior Notes—Our senior unsecured notes are callable by AHL at any time. If called prior to a defined period before the scheduled maturity date, typically three or six months, the price is equal to the greater of (1)100% of the principal and any accrued and unpaid interest and (2) an amount equal to the sum of the present values of remaining scheduled payments, discounted from the scheduled payment date to the redemption date at the treasury rate plus a spread as defined in the applicable prospectus supplement and any accrued and unpaid interest.
During the second quarter of 2025, we issued $1,000 million of 6.625% Senior Notes due May 19, 2055 (2055 Senior Notes). We will accrue interest quarterly and pay interest on the 2055 Senior Notes semi-annually, commencing on November 19, 2025.
Subordinated Notes—We have fixed-rate reset subordinated notes outstanding, which pay interest at the initially stated fixed rate until the interest rate reset dates, at which point the interest rate resets to the Five-Year US Treasury Rate plus a spread. Reset terms are as defined in the applicable prospectus supplement. We may defer interest payments on the subordinated notes for up tofive consecutive years.
During the second quarter of 2025, we issued $600 million of 6.875% Fixed-Rate Reset Junior Subordinated Debentures due June 28, 2055 (2055 Subordinated Notes). We will accrue interest quarterly and pay interest at an annual fixed rate of 6.875% on the 2055 Subordinated Notes semi-annually, commencing on December 28, 2025 until June 28, 2035. On June 28, 2035, and every fifth annual anniversary thereafter, the interest rate will reset to the Five-Year US Treasury Rate (as defined in the applicable prospectus supplement) plus 2.582%. We may defer interest payments for up tofive consecutive years.
The following is a summary of our debt:
| Outstanding Balance | ||||||
|---|---|---|---|---|---|---|
| (In millions, except percentages) · Issue Date · Maturity Date · Principal Balance · June 30, 2025 · December 31, 2024 | ||||||
| 4.125% 2028 Senior Notes | January 12, 2018 | January 12, 2028 | $1,000 | $1,042 | $1,050 | |
| 6.150% 2030 Senior Notes | April 3, 2020 | April 3, 2030 | 500 | 572 | 579 | |
| 3.500% 2031 Senior Notes | October 8, 2020 | January 15, 2031 | 500 | 518 | 520 | |
| 6.650% 2033 Senior Notes | November 21, 2022 | February 1, 2033 | 400 | 396 | 395 | |
| 5.875% 2034 Senior Notes | December 12, 2023 | January 15, 2034 | 600 | 585 | 584 | |
| 3.950% 2051 Senior Notes | May 25, 2021 | May 25, 2051 | 500 | 544 | 544 | |
| 3.450% 2052 Senior Notes | December 13, 2021 | May 15, 2052 | 500 | 504 | 504 | |
| 6.250% 2054 Senior Notes | March 22, 2024 | April 1, 2054 | 1,000 | 982 | 983 | |
| 6.625% 2055 Senior Notes | May 19, 2025 | May 19, 2055 | 1,000 | 979 | — | |
| 6.625% 2054 Subordinated Notes | October 10, 2024 | October 15, 2054 | 600 | 592 | 592 | |
| 6.875% 2055 Subordinated Notes | June 27, 2025 | June 28, 2055 | 600 | 592 | — | |
| 7.250% 2064 Subordinated Notes | March 7, 2024 | March 30, 2064 | 575 | 558 | 558 | |
| Total debt | $7,775 | $7,864 | $6,309 | |||
- Equity
Preferred Stock—On June 30, 2025, we redeemed in whole our 6.375% Fixed-Rate Reset Perpetual Non-Cumulative Preferred Stock, Series C (Series C) outstan ding for $25,000 per share of Series C preferred stock, or $600 million in total.
Common Stock—On August 5, 2025, our board of directors approved a reverse stock split of 1-for-1,000, which reduced our shares of common stock outstanding to 203,805 as of August 5, 2025, all of which continue to be held by AGM.
Accumulated Other Comprehensive Income (Loss)—The following provides the details and changes in AOCI:
| (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | Unrealized investment gains (losses) on AFS securities with a credit allowance | Unrealized gains (losses) on hedging instruments | Remeasurement gains (losses) on future policy benefits related to discount rate | Remeasurement gains (losses) on market risk benefits related to credit risk | Foreign currency translation and other adjustments | Accumulated other comprehensive income (loss) |
|---|---|---|---|---|---|---|---|
| Balance at March 31, 2025 | $(8,214) | $(313) | $(1) | $3,986 | $(23) | $4 | $(4,561) |
| Other comprehensive income (loss) before reclassifications | 1,258 | 58 | 1 | (45) | (135) | 78 | 1,215 |
| Less: Reclassification adjustments for gains (losses) realized in net income1 | (77) | (3) | 9 | — | — | — | (71) |
| Less: Income tax expense (benefit) | 268 | 13 | (2) | (6) | (28) | 15 | 260 |
| Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax | 234 | 5 | 20 | (96) | (15) | 5 | 153 |
| Balance at June 30, 2025 | $(7,381) | $(270) | $(27) | $4,043 | $(115) | $62 | $(3,688) |
| 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. | |||||||
| (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | Unrealized investment gains (losses) on AFS securities with a credit allowance | Unrealized gains (losses) on hedging instruments | Remeasurement gains (losses) on future policy benefits related to discount rate | Remeasurement gains (losses) on market risk benefits related to credit risk | Foreign currency translation and other adjustments | Accumulated other comprehensive income (loss) |
|---|---|---|---|---|---|---|---|
| Balance at March 31, 2024 | $(8,959) | $(404) | $(129) | $3,879 | $(17) | $2 | $(5,628) |
| Other comprehensive income (loss) before reclassifications | (1,069) | 148 | 97 | 628 | 34 | (5) | (167) |
| Less: Reclassification adjustments for gains (losses) realized in net income1 | 64 | (6) | 13 | — | — | — | 71 |
| Less: Income tax expense (benefit) | (229) | 32 | 18 | 128 | 8 | (1) | (44) |
| Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax | (193) | (5) | 20 | 161 | 4 | — | (13) |
| Balance at June 30, 2024 | $(9,670) | $(277) | $(83) | $4,218 | $5 | $(2) | $(5,809) |
| 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. | |||||||
| (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | Unrealized investment gains (losses) on AFS securities with a credit allowance | Unrealized gains (losses) on hedging instruments | Remeasurement gains (losses) on future policy benefits related to discount rate | Remeasurement gains (losses) on market risk benefits related to credit risk | Foreign currency translation and other adjustments | Accumulated other comprehensive income (loss) |
|---|---|---|---|---|---|---|---|
| Balance at December 31, 2024 | $(9,171) | $(284) | $(120) | $4,235 | $(103) | $(22) | $(5,465) |
| Other comprehensive income (loss) before reclassifications | 2,596 | 21 | 240 | (573) | (19) | 114 | 2,379 |
| Less: Reclassification adjustments for gains (losses) realized in net income1 | (268) | (3) | 19 | — | — | — | (252) |
| Less: Income tax expense (benefit) | 580 | 5 | 46 | (116) | (4) | 22 | 533 |
| Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax | 494 | 5 | 82 | (265) | (3) | 8 | 321 |
| Balance at June 30, 2025 | $(7,381) | $(270) | $(27) | $4,043 | $(115) | $62 | $(3,688) |
| 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. | |||||||
| (In millions) | Unrealized investment gains (losses) on AFS securities without a credit allowance | Unrealized investment gains (losses) on AFS securities with a credit allowance | Unrealized gains (losses) on hedging instruments | Remeasurement gains (losses) on future policy benefits related to discount rate | Remeasurement gains (losses) on market risk benefits related to credit risk | Foreign currency translation and other adjustments | Accumulated other comprehensive income (loss) |
|---|---|---|---|---|---|---|---|
| Balance at December 31, 2023 | $(8,672) | $(289) | $(82) | $3,458 | $3 | $13 | $(5,569) |
| Other comprehensive income (loss) before reclassifications | (1,614) | 3 | 39 | 1,431 | 6 | (21) | (156) |
| Less: Reclassification adjustments for gains (losses) realized in net income1 | 111 | (6) | 31 | — | — | — | 136 |
| Less: Income tax expense (benefit) | (346) | 2 | 2 | 296 | 2 | (4) | (48) |
| Less: Other comprehensive income (loss) attributable to noncontrolling interests, net of tax | (381) | (5) | 7 | 375 | 2 | (2) | (4) |
| Balance at June 30, 2024 | $(9,670) | $(277) | $(83) | $4,218 | $5 | $(2) | $(5,809) |
| 1 Recognized in investment related gains (losses) on the condensed consolidated statements of income. | |||||||
- Income Taxes
Theincome tax expense (benefit) was $(34) million and $161 million for the three months ended June 30, 2025 and 2024, respectively. Our effective tax rate was (5)% and 16% for the three months ended June 30, 2025 and 2024, respectively. Theincome tax expense was $141 million and $468 million for the six months ended June 30, 2025 and 2024, respectively. Our effective tax rate was 9% and 17% for the six months ended June 30, 2025 and 2024, respectively. The income tax expense considers US federal, US state, local and foreign income taxes. The most significant reconciling items relate to US noncontrolling interests and Bermuda corporate income tax.
On June 28, 2025, the Group of 7 (G7) released a joint statement supporting the exclusion of US-parented multinational groups from the Pillar Two Income Inclusion Rule and Undertaxed Profits Rule with respect to both domestic and foreign profits. While such a revision would likely apply to our wholly-owned entities, application to ACRA is uncertain given that we only partially own ACRA. In addition, it is uncertain whether Bermuda will revise its corporate income tax (CIT) regime in response to the G7’s statement. We continue to monitor these developments. Our results continue to reflect any impacts of Pillar Two and the Bermuda CIT on our US and non-US income, and if either regime changes, our consolidated financial statements could be affected.
On July 4, 2025, the US government enacted H.R. 1, which includes several tax-related provisions. We have evaluated the enacted legislation and concluded that it does not have a material impact on our consolidated financial statements.
- Related Parties
Apollo
Fee structure– Substantially all of our investments are managed by Apollo. Apollo provides us with a full suite of services for our investment portfolio, including direct investment management, asset allocation, mergers and acquisitions asset diligence, and certain operational support services including investment compliance, tax, legal and risk management support.
Apollo has extensive experience managing our investment portfolio and its knowledge of our liability profile enables it to tailor an asset management strategy to fit our specific needs. This strategy has proven responsive to changing market conditions and focuses on earning incremental yield by taking measured liquidity risk and complexity risk, rather than assuming incremental credit risk. Our partnership has enabled us to take advantage of investment opportunities that would likely not otherwise have been available to us.
Under our fee agreement with Apollo, we pay Apollo a base management fee of (1)0.225% per year on a monthly basis equal to the lesser of (A) $103.4 billion, which represents the aggregate fair market value of substantially all of the assets in substantially all of the accounts of or relating to us (collectively, the Accounts) as of December 31, 2018 (Backbook Value), and (B) the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month, plus (2)0.15% per year of the amount, if any, by which the aggregate book value of substantially all of the assets in the Accounts at the end of the respective month exceeds the Backbook Value, subject to certain adjustments. Additionally, we pay a sub-allocation fee based on specified asset class tiers ranging from 0.065% to 0.70% of the book value of such assets, with the higher percentages in this range for asset classes that are designed to have more alpha generating abilities. In addition to the base and sub-allocation fees specified above, we pay Apollo a target annual performance fee of $37.5 million, with the amount of the annual performance fee ranging from between 0% and 200% of such target amount, based on our spread related earnings for the year relative to our targets.
During the three months ended June 30, 2025 and 2024, we incurred management fees, inclusive of the base, sub-allocation and performance fees, of $383 million and $304 million, respectively. During the six months ended June 30, 2025 and 2024, we incurred management fees, inclusive of the base, sub-allocation and performance fees, of $754 million and $593 million, respectively. Management fees are included within net investment income on the condensed consolidated statements of income. As of June 30, 2025 and December 31, 2024, management fees payable were $148 million and $127 million, respectively, and are included in other liabilities on the condensed consolidated balance sheets. Such amounts include fees incurred attributable to Athene Co-Invest Reinsurance Affiliate Holding Ltd. (together with its subsidiaries, ACRA 1) and Athene Co-Invest Reinsurance Affiliate Holding 2 Ltd. (together with its subsidiaries, ACRA 2) including any noncontrolling interests associated with ACRA 1 and ACRA 2 (collectively, ACRA).
In addition to the assets on our condensed consolidated balance sheets managed by Apollo, Apollo manages the assets underlying our funds withheld receivable. For these assets, the third-party cedants pay Apollo fees based upon the same fee construct we have with Apollo. Such fees directly reduce the settlement payments that we receive from the third-party cedant and, as such, we indirectly pay those fees. Finally, Apollo charges management fees and carried interest on Apollo-managed funds and other entities in which we invest. Neither the fees paid by such third-party cedants nor the fees or carried interest paid by such Apollo-managed funds or other entities are included in the investment management fee amounts noted above.
Governance– We have an investment and asset liability committee, which includes members of our senior management and reports to the risk committee of our board of directors. The committee focuses on strategic decisions involving our investment portfolio, such as approving investment limits, new asset classes and our allocation strategy, reviewing large asset transactions, as well as monitoring our credit risk, and the management of our assets and liabilities.
AGM owns all of our common stock and James Belardi, our Executive Chairman and Chief Investment Officer, serves as a member of the board of directors and an executive officer of AGM, and Chief Executive Officer (CEO) of Apollo Insurance Solutions Group LP (ISG), which is also a subsidiary of AGM. Mr. Belardi also owns a profit interest in ISG and in connection with such interest receives quarterly distributions equal to 3.35% of base management fees and 4.5% of subadvisory fees, as such fees are defined in our fee agreement with Apollo. Additionally, six of thetwelve members of our board of directors (including Mr. Belardi) are employees of or consultants to Apollo. In order to protect against potential conflicts of interest resulting from transactions into which we have entered and will continue to enter into with the Apollo Group, our audit committee reviews and approves material transactions between us and the Apollo Group, subject to certain exceptions.
Other related party transactions
Apollo Aligned Alternatives Aggregator, L.P. (AAA)– We consolidate AAA as a VIE and AAA holds the majority of our alternative investment portfolio. Apollo established AAA to provide a single vehicle through which investors may participate in a portfolio of alternative investments, including those managed by Apollo. Additionally, we believe AAA enhances Apollo’s ability to increase alternative assets under management (AUM) by raising capital from third parties, which allows us to achieve greater scale and diversification for alternatives.
Athora Holding Ltd. (Athora) – We had an amended and restated cooperation agreement with Athora, which was terminated effective August 5, 2025. Pursuant to this agreement, among other things, (1) for a period of 30 days from the receipt of notice of a cession, we had the right of first refusal to reinsure (i) up to 50% of the liabilities ceded from Athora’s reinsurance subsidiaries to Athora Life Re Ltd. and (ii) up to 20% of the liabilities ceded from a third party to any of Athora’s insurance subsidiaries, subject to a limitation in the aggregate of 20% of Athora’s liabilities, and (2) Athora agreed to cause its insurance subsidiaries to consider the purchase of certain funding agreements and/or other spread instruments issued by our insurance subsidiaries, subject to a limitation that the fair market value of such funding agreements purchased by any of Athora’s insurance subsidiaries may generally not exceed 3% of the fair market value of such subsidiary’s total assets. As of June 30, 2025, we had not exercised our right of first refusal to reinsure liabilities ceded to Athora’s insurance or reinsurance subsidiaries.
We have investments in Athora’s equity, which we hold as a related party investment fund on the condensed consolidated balance sheets, and non-redeemable preferred equity and corporate debt securities. The following table summarizes our investments in Athora:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| Investment fund | $1,171 | $1,033 |
| Non-redeemable preferred equity and corporate debt securities | 316 | 277 |
| Total investment in Athora | $1,487 | $1,310 |
Additionally, as of June 30, 2025 and December 31, 2024, we had $65 million and $57 million, respectively, of funding agreements outstanding to Athora. We also had commitments to make additional investments in Athora of $277 million as of June 30, 2025. On July 3, 2025, we made a conditional commitment to invest, or cause one or more of our affiliates to invest, in Athora for up to an additional $2.5 billion, in connection with Athora’s agreement to acquire a UK insurer (Athora transaction). The Athora transaction remains subject to closing conditions, including receipt of regulatory approvals. The amount ultimately funded pursuant to the conditional commitment, and sources of funding, are subject to change as a result of an anticipated capital raise by Athora between signing and closing of the Athora transaction.
Atlas– We have an equity investment in Atlas, an asset-backed specialty lender, through our investment in AAA. As of June 30, 2025 and December 31, 2024, we held $4,584 million and $3,245 million, respectively, of related party AFS securities issued by Atlas or its affiliates. Additionally, we held $724 million of reverse repurchase agreements issued by Atlas as of December 31, 2024, which were included in related party short-term investments on the condensed consolidated balance sheets, and settled during the six months ended June 30, 2025. As of June 30, 2025, we had commitments to make additional investments in Atlas of $1,384 million. See Note 12 – Commitments and Contingencies for further information on assurance letters issued in support of Atlas.
Catalina– We have an investment in Apollo Rose II (B) (Apollo Rose). Apollo Rose holds common and preferred equity interests in Catalina Holdings (Bermuda) Ltd. (together with its subsidiaries, Catalina). As of June 30, 2025 and December 31, 2024, we held $202 million and $205 million, respectively, of redeemable preferred equity securities issued by Apollo Rose, which are held as related party AFS securities on the condensed consolidated balance sheets.
We have a strategic modco reinsurance agreement with Catalina to cede certain inforce funding agreements. We elected the fair value option on this agreement and had a liability of $235 million and $221 million as of June 30, 2025 and December 31, 2024, respectively, which is included in other liabilities on the condensed consolidated balance sheets. We also have a modco reinsurance agreement with Catalina to cede a quota share of retail deferred annuity products. As of June 30, 2025 and December 31, 2024, we had a reinsurance recoverable balance of $5,269 million and $4,309 million, respectively, related to this agreement.
MidCap FinCo Designated Activity Company (MidCap Financial)– We have various investments in MidCap Financial including an investment through AAA, senior unsecured notes and redeemable preferred stock. We also hold structured securities issued by MidCap Financial affiliates. As of June 30, 2025 and December 31, 2024, we held securities issued by MidCap Financial and its affiliates of $1,849 million and $1,938 million, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets.
Skylign Aviation Holdings, L.P. (together with its subsidiaries, Skylign) – We have investments in Skylign, a leading aviation finance group focused on aviation lending and leasing, both directly through notes issued by PK AirFinance, a subsidiary of Skylign, and indirectly through AAA. We had direct investments in Skylign notes of $1,503 million and $1,616 million as of June 30, 2025 and December 31, 2024, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets. We also had commitments to make additional investments in Skylign of $41 million as of June 30, 2025.
Strategic Partnership – We have an agreement pursuant to which we may invest up to $2.875 billion in funds managed by Apollo entities (Strategic Partnership). This arrangement is intended to permit us to invest across the Apollo alternatives platform in a manner and size that is consistent with our existing investment strategy. Fees for such investments payable by us to Apollo would be more favorable to us than market rates, and consistent with our existing alternative investments, investments made under the Strategic Partnership require approval of ISG and remain subject to our existing governance processes, including approval by our audit committee where applicable. As of June 30, 2025 and December 31, 2024, we held $1,959 million and $1,994 million, respectively, of investments under the Strategic Partnership and these investments are typically included as investments of consolidated VIEs or related party investment funds on the condensed consolidated balance sheets.
Venerable– VA Capital Company LLC (VA Capital) is owned by a consortium of investors, led by affiliates of Apollo, Crestview Partners III Management, LLC and Reverence Capital Partners L.P., and is the parent of Venerable Holdings, Inc. (together with its subsidiaries, Venerable). We have a minority equity investment in VA Capital, which was $198 million and $178 million as of June 30, 2025 and December 31, 2024, respectively, that is included in related party investment funds on the condensed consolidated balance sheets and accounted for as an equity method investment. We also had commitments to make additional investments in Venerable of $169 million as of June 30, 2025.
Additionally, we consolidate AP Violet ATH Holdings, L.P. and its investment fund primarily represents an interest in VA Capital, which was $123 million and $106 million as of June 30, 2025 and December 31, 2024, respectively.
We have coinsurance and modco agreements with VIAC, which is a subsidiary of Venerable. VIAC is a related party due to our investment in VA Capital. We also have term loans receivable from Venerable due in 2033, which are included in related party other investments on the condensed consolidated balance sheets. The loans are held at fair value and were $339 million and $331 million as of June 30, 2025 and December 31, 2024, respectively. While management views the overall transactions with Venerable as favorable to us, the stated interest rate of 6.257% on the initial term loan to Venerable represented a below-market interest rate, and management considered such rate as part of its evaluation and pricing of the reinsurance transactions.
Wheels Inc. (Wheels) – We invest in Wheels indirectly through our investment in AAA. We also directly hold securities issued by Wheels of $974 million and $984 million as of June 30, 2025 and December 31, 2024, respectively, which are included in related party AFS securities on the condensed consolidated balance sheets. We also had commitments to make additional investments in Wheels of $32 million as of June 30, 2025.
ACRA and Apollo/Athene Dedicated Investment Programs I and II (collectively, ADIP) – ACRA 1 is partially owned by Apollo/Athene Dedicated Investment Program (ADIP I), a series of funds managed by Apollo. ALRe directly holds 37% of the economic interests in ACRA 1 and all of ACRA 1’s voting interests, with ADIP I holding the remaining 63% of the economic interests. ACRA 2 is partially owned by Apollo/Athene Dedicated Investment Program II (ADIP II), a fund managed by Apollo. ADIP II owns 63% of the economic interests in ACRA 2, with ALRe directly owning the remaining 37% of the economic interests. ALRe holds all of ACRA 2’s voting interests.
We received capital contributions and paid distributions relating to ACRA of the following:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Contributions from ADIP | $126 | $300 | $126 | $705 |
| Distributions to ADIP | (95) | (254) | (190) | (508) |
Additionally, as of June 30, 2025 and December 31, 2024, we had $333 million and $289 million, respectively, of related party payables for contingent investment fees payable by ACRA to Apollo. ACRA is obligated to pay the contingent investment fees on behalf of ADIP and, as such, the balance is attributable to the noncontrolling interests.
As of June 30, 2025 and December 31, 2024, we held investments in ADIP of $236 million and $238 million, respectively, which are accounted for as equity method investments and included in related party investment funds on the condensed consolidated balance sheets. As of June 30, 2025, we also had commitments to make additional investments in ADIP of $328 million.
Unsecured Revolving Promissory Note Receivable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AGM to borrow funds from AHL. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AHL’s request. The note receivable had an outstanding balance of $177 million and $142 million as of June 30, 2025 and December 31, 2024, respectively.
Unsecured Revolving Promissory Note Payable with AGM – AHL has an unsecured revolving promissory note with AGM which allows AHL to borrow funds from AGM. The note has a borrowing capacity of $500 million. Interest accrues at the US mid-term applicable federal rate per year and has a maturity date of December 13, 2025, or earlier at AGM’s request. There wasno outstanding balance on the note payable as of June 30, 2025 and December 31, 2024.
- Commitments and Contingencies
Contingent Commitments—We had commitments to make investments, inclusive of related party commitments discussed previously and those of consolidated VIEs, of$33.3 billionas of June 30, 2025. These commitments primarily include capital contributions to investment funds and mortgage loan commitments. We expect most of our current commitments will be invested over the next five years; however, these commitments could become due any time upon counterparty request.
Funding Agreements—Weare a member of the Federal Home Loan Bank of Des Moines (FHLB) and, through membership, we have issued funding agreements to the FHLB in exchange for cash advances. As of June 30, 2025 and December 31, 2024, we had $21.0 billion and $15.6 billion, respectively, of FHLB funding agreements outstanding. We are required to provide collateral in excess of the funding agreement amounts outstanding, considering any discounts to the securities posted and prepayment penalties.
We have a funding agreement backed notes (FABN) program, which allows Athene Global Funding, a special-purpose, unaffiliated statutory trust, to offer its senior secured medium-term notes. Athene Global Funding uses the net proceeds from each sale to purchase one or more funding agreements from us. As of June 30, 2025 and December 31, 2024, we had $30.4 billion and $24.1 billion, respectively, of FABN funding agreements outstanding. We had $5.0 billion of board-authorized FABN capacity remaining as of June 30, 2025.
We also issue secured and other funding agreements. Secured funding agreements issued under our funding agreement backed repurchase agreement (FABR) programs involve special-purpose, unaffiliated entities entering into repurchase agreements with a third party, the proceeds of which are used by the special-purpose entities to purchase funding agreements from us. As of June 30, 2025 and December 31, 2024, we had $23.2 billion and $14.8 billion, respectively, of secured and other funding agreements outstanding, of which $18.0 billion and $12.0 billion were issued under the FABR program, respectively, and $5.2 billion and $2.8 billion were direct funding agreements, respectively.
Pledged Assets and Funds in Trust (Restricted Assets)—The restricted investments and cash balances included on the condensed consolidated balance sheets are as follows:
| (In millions) | June 30, 2025 | December 31, 2024 |
|---|---|---|
| AFS securities | $57,451 | $46,337 |
| Trading securities | 3,045 | 1,665 |
| Equity securities | 246 | 286 |
| Mortgage loans | 36,249 | 27,883 |
| Investment funds | 288 | 777 |
| Derivative assets | 158 | 91 |
| Short-term investments | — | 2 |
| Other investments | 1,733 | 1,507 |
| Restricted cash | 1,737 | 953 |
| Total restricted assets | $100,907 | $79,501 |
The restricted assets are primarily related to reinsurance trusts established in accordance with coinsurance agreements and the FHLB andsecured funding agreements described above.
Letters of Credit—We have undrawn letters of credit totaling $1,147 million as of June 30, 2025. These letters of credit were issued for our reinsurance program and have expirations through June 19, 2028.
Assurance Letter—In connection with our, Apollo and Credit Suisse AG’s (CS) previously announced transaction, Atlas acquired certain assets of the CS Securitized Products Group and agreed to pay CS a deferred purchase obligation of $3.3 billion. In March 2024, in connection with Atlas concluding its investment management agreement with CS, the deferred purchase obligation amount was reduced to $2.5 billion. In addition, certain strategic investors have made equity commitments to Atlas which therefore obligates these investors for a portion of the deferred purchase obligation. This deferred purchase price is an obligation first of Atlas, and (as a result of additional guarantees provided by AAA, Apollo Asset Management, Inc. (AAM) and AHL) second of AAA, third of AAM, fourth of AHL and fifth of AARe. AARe and AAM each issued an assurance letter to CS to guarantee the full amount. Our guarantees are not probable of payment; therefore, no liabilities have been recorded for the guarantees on the condensed consolidated financial statements.
- Segment Information
We operate our core business strategies throughone reportable segment. We conduct our retirement services business through entities domiciled in the US and Bermuda and our revenues are similarly generated primarily in the US and Bermuda. Our CEO is the Chief Operating Decision Maker (CODM), who is also solely responsible for decisions related to the allocation of resources on a company-wide basis. For determining the allocation of resources, the CODM reviews the Company’s performance based on its key measure of condensed consolidated net income to evaluate income generated and determine allocation of resources, among other measures.
Measures that the CODM reviews also include the significant expenses of cost of funds, other operating expenses, and interest and other financing costs that each exclude the proportionate share associated with noncontrolling interests. Cost of funds reflect the cost of crediting on both deferred annuities and institutional products, as well as other liability costs, net of premium from life and life-contingent products and other revenues. Certain expenses within cost of funds, notably future policy and other policy benefits, are partially or fully offset in the presentation of cost of funds with inflows of premium and other fee-related revenues; as a result, other liability costs equal to the amount of premium from life and life-contingent products are added back in the reconciliation below to reflect the expense amount excluded from cost of funds. Other operating expenses consist primarily of employee compensation and general operating costs of the business. Interest and other financing costs consist primarily of preferred stock dividends and interest expense on our debt issuances, as well as other financing.
Additionally, total condensed consolidated assets is the only measure of segment assets that the CODM uses to determine allocation of resources.
The reconciliation of total condensed consolidated revenue to total condensed consolidated net income is as follows:
| Three months ended June 30, | Six months ended June 30, | |||
|---|---|---|---|---|
| (In millions) | 2025 | 2024 | 2025 | 2024 |
| Revenues | $5,359 | $4,664 | $9,545 | $10,385 |
| Less: | ||||
| Cost of funds | 2,470 | 1,880 | 4,680 | 3,603 |
| Other operating expenses | 109 | 116 | 225 | 232 |
| Interest and other financing costs | 132 | 119 | 262 | 210 |
| Other liability costs equal to the amount of premium | 107 | 673 | 234 | 774 |
| Other segment items1 | 1,889 | 849 | 2,558 | 2,757 |
| Income before income taxes | 652 | 1,027 | 1,586 | 2,809 |
| Income tax expense (benefit) | (34) | 161 | 141 | 468 |
| Net income | $686 | $866 | $1,445 | $2,341 |
| 1 Other segment items reflect the difference between revenues and significant segment expenses and include the impact of fair value accounting for market risk benefits, embedded derivative remeasurement, the amortization of purchased options on fixed indexed annuities and noncontrolling interests. | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.